Phase II

Phase II Annual Planner 2024-25

MONTH	DAY	8 - 11 am	11-12 pm	Lunch 12-1 pm	1-2 pm	2-3 pm	3-4 pm
FIRST MONTH	DAY 1	CLINICAL POSTING	IM 8.31.SYSTEMIC HYPERTENSION		PH 1.1 PRINCIPLES OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS	MI 1.1 INTRO AND MORPHOLOGY OF BACTERIA	FM 1.1 BASICS OF FORENSIC MEDICINE
	DAY 2	CLINICAL POSTING	SU 1.1 Basic Concept of hemostasis, metabolic changes in injury & their mediators.		PATH 1.1,1.2,1.3 INTRODUCTION TO PATHOLOGY	MI 1.1 INTRO AND MORPHOLOGY OF BACTERIA	MI 1.2 MICROSCOPY - DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.4 ABSORPTION, DISTRIBUTION (SGD)	PA 2.4 CELL DEATH NECROSIS (SGD)	DOAP PATH 1.1,1.2,1.3 INTRODUCTION TO PATHOLOGY
	DAY 4	CLINICAL POSTING	2.2 CM 7.7, 8.4, 8.5 INVESTIGATION, PREVENTION AND CONTROL STRATEGIES FOR EMERGING AND RE-EMERGING INFECTIOUS DISEASES AT COMMUNITY LEVEL		MI 1.1 CULTURE MEDIA AND METHODS9(SGD)	PA 2.4 CELL DEATH APOPTOSIS (SGD)	PH 1.3,1.11- ROUTES OF DRUG ADMINISTRATION, DRUG DELIVERY SYSTEM AND FORMULATIONS (DOAP)
	DAY 5	CLINICAL POSTING	2.3 Sample collection procedures I (SGD)		PA 2.1, 2.2 CELL INJURY PA 2.3 INTRACELLULAR ACCUMULATIONS (SGD)	DOAP - PH 1.3,1.11- ROUTES OF DRUG ADMINISTRATION, DRUG DELIVERY SYSTEM AND FORMULATIONS	DOAP - PH 4.1 ADMINISTER DRUGS THROUGH VARIOUS ROUTES IN A SIMULATED ENVIRONMENT USING MANNEQUINES
	DAY 6	CLINICAL POSTING	AETCOM MODULE 2.5 IDENTY, DISCUSS AND DEFINED MEDICO - LEGAL, SOCIO - LEGAL, SOCIO - CULTURAL AND ETHICAL ISSUES AS IT PERTAINS TO PATIENT AUTONOMY, PATIENT RIGHTS AND SHARED RESPONSIBILITY IN HEALTH CARE
	DAY 7
	DAY 1	CLINICAL POSTING	IM 2.1 ACUTE MYOCARDIAL INFARCTION/IHD		PH 2.1 UNDERSTANDING OF THE USE OF VARIOUS DOSAGE FORMS	MI 1.1 INTRODUCTION TO VIROLOGY AND DIAGNOSTIC METHODS	FM 1.1 BASICS OF CLINICAL FORENSIC MEDICINE
	DAY 2	CLINICAL POSTING	SU 1.2 Factors affecting metabolic response to injury		PA 2.5, 2.7-PATHOLOGICAL CALCIFICATION, GANGRENE, CELLULAR AGEING (SGD)	MI 1.1 INTRODUCTION TO PARASITOLOGY AND DIAGNOSTIC METHODS	MI 1.2 GRAM STAIN - DOAP
	DAY 3	CLINICAL POSTING	2.2 CM 8.1 EPIDEMIOLOGY OF H1N1 INFLUENZA AND COVID 19 PANDEMIC (SGD)		PH 1.4 METABOLISM (SGD)	2.6 CELLULAR ADAPTATIONS (SGD)	DOAP PATH 2.8 VARIOUS FORMS OF CELL INJURY
	DAY 4	CLINICAL POSTING	2.2 CM 8.1 EPIDEMIOLOGY OF EBOLA AND NIPAH VIRUS DISEASE (SGD)		MI 1.1 BACTERIOPHAGE, VIRUS HOST INTERACTION	PA 4.1 GENERAL FEATURES OF ACUTE AND CHRONIC INFLAMMATION	PH 1.4 EXCRETION OF DRUGS (SGD)
	DAY 5	CLINICAL POSTING	2.3 Sample collection procedures II(SGD)		4.2 MEDIATORS OF ACUTE INFLAMMATION (SGD)	SGD PH1.9,1.11 NOMENCLATURE OF DRUGS, SOURCES OF DRUGS, ROUTES OF DRUG ADMINISTRATION	SGD PH 1.9,1.11 NOMENCLATURE OF DRUGS, ROUTES OF DRUG ADMINISTRATION
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 1.1 HEART FAILURE		PH 1.4 EXCRETION OF DRUGS (SGD)	MI 1.1 BACTERIOPHAGE, VIRUS HOST INTERACTION	FM 1.1 BASICS OF FORENSIC PATHOLOGY,STATE MEDICINE
	DAY 2	CLINICAL POSTING	P 4.3 CHRONIC INFLAMMATION (SGD), SYSTEMIC EFFECTS OFINFLAMMATION		P 4.3 CHRONIC INFLAMMATION (SGD), SYSTEMIC EFFECTS OFINFLAMMATION	MI 1.1 INTRODUCTION TO PARASITOLOGY AND DIAGNOSTIC METHODS	MI 1.2 GRAM STAIN - DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.2 EVIDENCE BASED MEDICINE , THERAPEUTIC DRUG MONITORING	PA 3.1 AMYLOIDOSIS (SGD)	DOAP PATH 2.8 VARIOUS FORMS OF CELL INJURY
	DAY 4	CLINICAL POSTING	2.2 CM 7.7, 8.4, 8.5 INVESTIGATION, PREVENTION AND CONTROL STRATEGIES FOR EBOLA AND NIPAH VIRUS DISEASE AT COMMUNITY LEVEL		1.1 INTRODUCION TO MYCOLOGY AND DIAGNOSTIC METHODS	PA 5.1 PROCESS OF REPAIR AND REGENERATION (SGD)	PH 1.5 MECHANISM OF DRUG ACTION (SGD)
	DAY 5	CLINICAL POSTING	2.3 Microbial diagnosis I(SGD)		6.1, 6.2 EDEMA, HYPEREMIA, CONGESTION, HEMORRHAGE (SGD)	SGD PH 2.1 DEMONSTRATE UNDERSTANDING THE USE OF VARIOUS DOSAGE FORMS (ORAL/LOCAL/PARENTERAL; SOLID/LIQUID)	SGD PH 2.1 DEMONSTRATE UNDERSTANDING THE USE OF VARIOUS DOSAGE FORMS (ORAL/LOCAL/PARENTERAL; SOLID/LIQUID)
	DAY 6	CLINICAL POSTING	AT COM Module - 2.1, DEMONSTRATE ABILITY TO COMMUNICATE TO PATIENT IN A PATIENT, RESPECTFUL, NON THREATENING, NON JUDGEMENTAL AND EMPATHETIC MANNER				SPORTS AND EXTRA CURRICULAR ACTIVITY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 3.1 PNEUMONIA		PH 1.5 MECHANISM OF DRUG ACTION (SGD)	1.1Bacterial genetics	FM 1.1 BASICS OF LEGAL MEDICINE
	DAY 2	CLINICAL POSTING	SU 2.1 Pathophysiology of Shocks types of shocks, principles of resuscitation fluid replacement & monitoring		PA 6.3 SHOCK (SGD)	MI 1.1 NORMAL FLORA(SDL)	MI 1.2 GRAM STAIN - DOAP
	DAY 3	CLINICAL POSTING	2.4 CM 10.5 UNIVERSAL IMMUNIZATION PROGRAMME - COLD CHAIN, MICROPLANNING, VACCINATION SCHEDULE, ROUTINE AND SUPPLEMENTARY IMMUNIZATION			PA 6.4 NORMAL HEMOSTASIS AND THROMBOSIS (SDL)	DOAP PATH - CHRONIC INFLAMMATION
	DAY 4	CLINICAL POSTING	2.4 CM 8.5, 8.6 PLANNING, IMPLEMENTING AND EVALUATING VACCINATION PROGRAMME DURING PANDEMIC		MI 1.1 MICROBIAL PATHOGENECITY	PA 6.5, 6.6 EMBOLISM, ISCHEMIA, INFARCTION (SGD)	PH 1.60 PHARMACOGENOMICS
	DAY 5	CLINICAL POSTING	2.3 Microbial diagnosis II(SGD)		PA 7.1 DEFINE AND CLASSIFY NEOPLASIA- BENIGN AND MLIGNANT, EPIDEMIOLOGY OF CANCER (SGD)	SGD PH 2.4 DEMONSTRATE THE CORRECT METHOD OF CALCULATION OF DRUG DOSAGE IN PATIENTS INCLUDING THOSE USED IN SPECIAL SITUATIONS	SGD PH 2.4 DEMONSTRATE THE CORRECT METHOD OF CALCULATION OF DRUG DOSAGE IN PATIENTS INCLUDING THOSE USED IN SPECIAL SITUATIONS
	DAY 6	CLINICAL POSTING	2.1 Infection Control Practices - Airborne precautions, Contact Precuations, Infection Control Committee
	DAY 7
SECOND MONTH	DAY 1	CLINICAL POSTING	IM 9.1 ANAEMIA		PH 1.60 PHARMACOECONOMICS	MI 1.3 EPIDEMEOLOGICAL BASIS OF INFECTIOUS DISEASES	MEDICOLEGAL AUTOPSY CLASS-INTRODUCTION
	DAY 2	CLINICAL POSTING	SU 2.2 Clinical Features of shock & it’s appropriate treatment		PA 7.3 CARCINOGENESIS (SGD)	MI 1.4 METHODS OF STERILISATION AND DISINFECTION(SGD)	MI 1.2 GRAM STAIN - DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.63 DRUG REGULATIONS	PA 7.2 MOLECULAR BASIS OF CANCER(SGD)	DOAP PRACTICALS - CHRONIC INFLAMMATION
	DAY 4	CLINICAL POSTING	2.4 CM - PLANNING, IMPLEMENTING AND EVALUATING VACCINATION PROGRAMME FOR COVID 19 PANDEMIC (SGD)		MI 1.5 EQUIPMENTS IN STERILISATION AND DISINFECTION	PA 7.2 MOLECULAR BASIS OF CANCER (SGD)	PH 1.7 MANAGEMENT OF ADR
	DAY 5	CLINICAL POSTING	2.3 Serological tests and their performance parameters I(SGD)		PA 7.2 MOLECULAR BASIS OF CANCER (SGD)	SGD PH.1.10 Describe Parts of a correct ,complete and legilible prescription. Identify errors in prescription and correct appropriately.	SGD PH.1.10 Describe Parts of a correct ,complete and legilible prescription. Identify errors in prescription and correct appropriately.
	DAY 6	CLINICAL POSTING	IA 1 PATH - 1			AETCOM MODULE 2.5 IDENTY, DISCUSS AND DEFINED MEDICO - LEGAL, SOCIO - LEGAL, SOCIO - CULTURAL AND ETHICAL ISSUES AS IT PERTAINS TO PATIENT AUTONOMY, PATIENT RIGHTS AND SHARED RESPONSIBILITY IN HEALTH CARE
	DAY 7
	DAY 1	CLINICAL POSTING			1.64 PHASES OF CLINICAL TRIALS, NEW DRUG DEVELOPMENT	MI 1.5 APPROPRIATE METHOD OF STERILISATION AND DISINFECTION IN SPECIAL SITUATIONS(SGD)	FM 1.1 MEDICAL JURISPRUDENCE	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	Su 3.1 Blood products & Complications of blood transfusion		PA 11.1 COMMON CYTOGENETIC MUTATIONS IN CHILDHOOD (SGD)	MI 1.7 STRUCTURE AND FUNCTION OF IMMUNE SYSTEM	MI 1.2 GRAM STAIN-DOAP
	DAY 3	CLINICAL POSTING	CM8.1 Epidemiology of Smallpox/Chicken pox		PH 1.64 GOOD CLINICAL PRACTICE	PA 11.1 COMMON CYTOGENETIC MUTATIONS IN CHILDHOOD (SGD)	PRACTICALS MICRO 1.2 GRAM STAIN DOAP PATH 6.7 INFARCT
	DAY 4	CLINICAL POSTING	CM8.1 Epidemiology of Measles,Mumps and Rubella		MI 1.7 ANTIGEN	PA 7.4 EFFECTS OF TUMOUR ON HOST (SGD), HOST DEFENCE AGAINST TUMOURS, LAB DIAGNOSIS OF CANCER	SDL - PH 1.8 MANAGEMENT OF DRUG INTERACTIONS
	DAY 5	CLINICAL POSTING	2.3 Serological tests and their performance parameters I(SGD)		PA 7.4 EFFECTS OF TUMOUR ON HOST (SGD), HOST DEFENCE AGAINST TUMOURS, LAB DIAGNOSIS OF CANCER	SDL - BIO ASSAY AND BIOSTANDARDISATION	DOAP - PH 4.1 ADMINISTER DRUGS THROUGH VARIOUS ROUTES IN A SIMULATED ENVIRONMENT USING MANNEQUINES
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 4.1 PYREXIA OF UNKNOWN ORIGIN		PH 1.6 PHARMACOVIGILANCE & ADR REPORTING SYSTEMS	MI 1.10 COMMONLY USED SEROLOGICAL DIAGNOSTIC METHODS	F.M 1.2 HISTORY OF FORENSIC MEDICINE
	DAY 2	CLINICAL POSTING	Su 4.2 Clinical Features of burns & appropriate management		PA 9.1 PRINCIPLES AND MECHANISMS OF IMMUNITY	MI 1.7 ANTIBODY	MI 1.2 GRAM STAIN - DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.14 ANS, CHOLINERGICS (SGD)	P 9.2 HYPERSENSITIVITY DISORDERS (SGD)	DOAP PATH 6.7 INFARCT
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Influenza&SARS		MI 1.10 COMMONLY USED SEROLOGICAL DIAGNOSTIC METHODS(SGD)	P 9.2 HYPERSENSITIVITY DISORDERS (SGD)	PH 1.14 ANS, ANTICHOLINERGICS (SGD)
	DAY 5	CLINICAL POSTING	2.2 Emerging and Re emerging infections - early diagnosis I (SGD)		PA 9.3 HLA, TRANSPLANT REJECTION (SGD)	SGD PH 3.4 To Recognize and report an adverse drug reaction	SGD PH 3.4 To Recognize and report an adverse drug reaction
	DAY 6	CLINICAL POSTING	IA - GENERAL Pharmacology			AETCOM - 2.4 1. DEMONSTRATE ABILITY TO WORK IN A TEAM OF PEERS AND SUPERIORS	SPORTS AND EXTRA CURRICULAR ACTIVITY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 5.18 JAUNDICE		PH 1.14 ANS, ANTICHOLINERGICS (SGD)	MI 1.7 COMPLEMENT	FM 1.3 LEGAL PROCEDURE
	DAY 2	CLINICAL POSTING	S U 5.1 Wound Healing & factors affecting wound healing		PA 9.4 AUTOIMMUNITY (SGD)	MI 1.10 AUTOIMMUNITY	MI 1.2 GRAM STAIN - DOAP	INTEGRATION WITH PATHOLOGY
	DAY 3	CLINICAL POSTING	CM8.1Epidemiology of Swine Flu&Avian Flu		PH 1.13 ADRENERGICS (SGD)	PA 9.5 AUTOIMMUNE DISORDERS SLE (SGD)	DOAP PATH 3.2 AMYLOIDOSIS IN SPECIMEN
	DAY 4	CLINICAL POSTING	CM8.1 Epidemiology of Tuberculosis - 1		MI 1.9 IMMUNOLOGICAL BASIS OF VACCINE AND UIP(SGD)		PH 1.13 ANTIADRENERGICS (SGD)
	DAY 5	CLINICAL POSTING	2.2 Emerging and Re emerging infections - early diagnosis II(SGD)		PA PRIMARY IMMUNODEFICIENCY DISORDERS	SGD PH 1.12 PEDIATRIC AND GERIATRIC DOSAGE CALCULATION	SGD PH 1.12 PEDIATRIC AND GERIATRIC DOSAGE CALCULATION
	DAY 6	CLINICAL POSTING	IA I - Microbiology / AETCOM MODULE 2.2: describe and discuss the role of autonomy and shared resonsibility as a guiding principle in patient care
	DAY 7
THIRD MONTH	DAY 1	CLINICAL POSTING	IM 18.1 STROKE		PH 1.13 ANTIADRENERGICS (SGD)	MI 1.8 IMMUNE RESPONSE	FM 1.3 CRIMINAL PROCEDURE CODE
	DAY 2	CLINICAL POSTING	SU 5.3 Types of Wound & management of wounds		PA 9.6 HIV AND AIDS (INTEGRATION)	MI 2.7 AIDS	MI 1.2 GRAM STAIN - DOAP	INTEGRATION WITH MICRO
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		SGD PH 1.58 DRUGS USED IN OCULAR DISORDERS	PA 9.7 OTHER AUTOIMMUNE DISORDERS	DOAP PATH 8.3 CYTOLOGYSTAINING
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Acute Respiratory Infections		MI 1.10 ANTIGEN ANTIBODY REACTION (SGD)	PA CONGENITAL HEART DISEASE	PH 1.17 LOCAL ANASTHETICS
	DAY 5	CLINICAL POSTING	2.2 Emerging and Re emerging infections - early diagnosis III(SGD)		PA 7.5 IMMUNE RESPONSE TO CANCER (SDL)	SGD PH 3.2 PERFORM AND INTERPRET A CRITICAL APPRAISAL(AUDIT) OF A GIVEN PRESCRIPTION	SGD PH 3.2 PERFORM AND INTERPRET A CRITICAL APPRAISAL(AUDIT) OF A GIVEN PRESCRIPTION
	DAY 6	CLINICAL POSTING	IA - PATH - 2			AETCOM MODULE 2.5 IDENTY, DISCUSS AND DEFINED MEDICO - LEGAL, SOCIO - LEGAL, SOCIO - CULTURAL AND ETHICAL ISSUES AS IT PERTAINS TO PATIENT AUTONOMY, PATIENT RIGHTS AND SHARED RESPONSIBILITY IN HEALTH CARE
	DAY 7
	DAY 1	CLINICAL POSTING	IM 18.17 CVA		PH 1.15 SKELETAL MUSCLE RELAXANTS	MI 1.9 INFECTION AND IMMUNITY(SDL)	FM 1.3 INDIAN PENAL CODE,INDIAN EVIDENCE ACT
	DAY 2	CLINICAL POSTING	PA - TB LUNG (SGD)		PA - TB LUNG (SGD)	MI 1.11 IMMUNOLOGY OF TRANSPLANTATION(SGD)	MI1.2 GRAM STAIN -DOAP
	DAY 3	CLINICAL POSTING	CM8.1Epidemiology of Typhoid		PH 1.16 NSAIDS	PA 10.2 CYSTICERCOSISPA 10.4 COMMON BACTERIAL, VIRAL, PROTOZOAL INFECTIONS (SDL)	DOAP PATH 8.3 CYTOLOGYSTAINING, TB
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Food Poisoning		MI 1.11 IMMUNOLOGY OF TRANSPLANTATION(SGD)	PA 10.4 COMMON BACTERIAL, VIRAL, PROTOZOAL INFECTIONS (SDL)	PH 1.16 NSAIDS
	DAY 5	CLINICAL POSTING	Social obstetrics		PA 11.1 COMMON CYTOGENETIC MUTATIONS IN CHILDHOOD (SGD)	SDL : - DRUGS AFFECTING PEPTIDE DERIVED AUTACOIDS	SGD - PH 1.16 5 HT MODULATING DRUGS & DRUGS FOR MIGRAINE
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING			PH 1.16 PROSTAGLANDINS, LEUKOTRIENES AND PLATELET ACTIVATING FACTOR	MI 1.11 TUMOUR IMMUNITY	FM 1.3 CIVIL & CRIMINAL CASES	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	PA 10.1 PATHOGENESIS AND PATHOLOGY OF MALARIA PA 10.3 LEPROSY		PA 27.4, 27.6 RHEUMATIC FEVER, INFECTIVE ENDOCARDITIS	MI 2.1 RHEUMATIC FEVER AND DIAGNOSIS	MI 1.2 GRAM STAIN-DOAP	INTEGRATION WITH PATHOLOGY
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.24 DIURETICS	PA 11.1 COMMON CYTOGENETIC MUTATIONS IN CHILDHOOD (SGD)	PRACTICALS MICRO 1.2 GRAM STAIN DOAP PATH 27.8 ABNORMALITIES IN CFT IN ACUTE CORONARY SYNDROME
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Soil borne Helminths		MI 1.10 IMMUNODEF DISORDERS	PA 11.3 STORAGE DISORDERS OF CHILDHOOD (SDL)	SDL - G87PH 1.24ANTI-DIURETICS
	DAY 5	CLINICAL POSTING	Anatomy of the uterus		PA 11.3 STORAGE DISORDERS OF CHILDHOOD (SDL)	DOAP - PH 4.1 ADMINISTER DRUGS THROUGH VARIOUS ROUTES IN A SIMULATED ENVIRONMENT USING MANNEQUINES	DOAP - PH 4.1 ADMINISTER DRUGS THROUGH VARIOUS ROUTES IN A SIMULATED ENVIRONMENT USING MANNEQUINES
	DAY 6	CLINICAL POSTING	IA - ANS			AETCOM - 2.4 1. DEMONSTRATE ABILITY TO WORK IN A TEAM OF PEERS AND SUPERIORS	SPORTS AND EXTRA CURRICULAR ACTIVITY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 17.1 HEADACHE		PH 1.25 ANTIPLATELETS	MI 2.2 INFECTIVE ENDOCARDITIS(SGD)	FM 1.3 POLICE INQUEST & MAGISTRATE INQUEST
	DAY 2	CLINICAL POSTING	Su 6.1 Aetiology and pathogenesis of surgical infection		PA 12.1 AIR POLLUTION (SDL)	MI 7.1 PATHOGENESIS &LAB DIAG OF INF IN GENITOURINARY SYSTEM(SGD)	MI 1.2 AFB DOAP
	DAY 3	CLINICAL POSTING	CM8.1 Epidemiology of Viral Hepatitis		PH 1.25 ANTICOAGULANTS	PA 12.1 TOBACCO, ALCOHOL DISORDERS (SDL)	DOAP PATH PA 13.5, 14.3 PERIPHERAL SMEAR
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Acute Diarrhoeal Disease		MI 1.10 Hypersensitivity	PA OBESITY	SGD - PH 1.25 FIBRINOLYTICS AND PLASMA EXPANDERS
	DAY 5	CLINICAL POSTING	Anatomy of the ovaries		PA 27.1 ATHEROSCLEROSIS (SGD)	SGD PH 1.28 DRUGS FOR ISCHEMIC HEART DESEASE & MI	SGD PH 1.28 DRUGS FOR ISCHEMIC HEART DESEASE & MI	INTEGRATED WITH PATH AND MEDICINE
	DAY 6	CLINICAL POSTING			AET COM - Micro: Module 2.2 : Describe and discuss the role of non-maleficence as a guiding principle in patient care
	DAY 7
FOURTH MONTH	DAY 1	CLINICAL POSTING	PH1.29 DRUGS USED IN CONGESTIVE HEART FAILURE		PH1.29 DRUGS USED IN CONGESTIVE HEART FAILURE	MI 7.3 CULTURE IDENTIFICATION OF E.COLI, KLEBSIELLA, PROTEUS(SGD)	AUTOPSY CLASS-INTRODUCTION,INCISION,PROCEDURE	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	S U 7.1 Surgical Audit		PA 27.3 HEART FAILURE, VALVULAR HEART DISEASE	MI 7.2 SEXUALLY TRANSMITTED INFECTIONS(SGD)	MI 1.2 AFB - DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.31 DRUGS FOR DYSLIPIDEMIA (SDL)	PA 11.2 TUMOUR AND TUMOUR LIKE LESIONS OF CHILDHOOD (SGD)	DOAP PATH PA 13.5, 14.3 PERIPHERAL SMEAR
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Plague		MI 2.5 Systemic Mycoses	PA 27.9 CARDIOMYOPATHIES, ARRYTHMIAS (SGD)	PH 1.30 ANTIARRHYTHMIC DRUGS	INTEGARTED PATH
	DAY 5	CLINICAL POSTING	Anatomy of Fallopian tubes		PA 27.7, 27.10 PERICARDITIS, PERICARDIAL EFFUSION, SYPHILIS IN CVS, CARCINOID, PROSTHETIC VALVES (SDL)	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT AUTOCOIDS	SGD PH 3.5 TO PREPARE AND EXPLAIN A LIST OF P-DRUGS FOR A GIVEN CASE/CONDITION
	DAY 6	CLINICAL POSTING	IA - PATH - 3			AETCOM MODULE 2.5 IDENTY, DISCUSS AND DEFINED MEDICO - LEGAL, SOCIO - LEGAL, SOCIO - CULTURAL AND ETHICAL ISSUES AS IT PERTAINS TO PATIENT AUTONOMY, PATIENT RIGHTS AND SHARED RESPONSIBILITY IN HEALTH CARE
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.27 DRUGS FOR SHOCK		SDL - PH 1.28 DRUGS USED IN PERIPHERAL VASCULAR DISEASE	MI 2.5 Filaria	FM 1.4 COURTS IN INDIA	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	Su 14.1 Aseptic techniques sterilization and disinfection		PA HYPERTENSION, HYPERTENSIVE HEART DISEASE	MI 2.5 KALA AZAR(SGD)	MI 1.2 AFB - DOAP
	DAY 3	CLINICAL POSTING	CM8.1Epidemiology of Rabies		PH 1.26 DRUGS MODULATING RENIN ANGIOTENSIN AND ALDOSTERONE SYSTEM	PA VASCULITIS	DOAP PATH PA 16.6 PERIPHERAL SMEAR HEMOLYTIC ANEMIA
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Yellow Fever /Kayanur fever disease		MI 2.5 Common Parasites prevalent in India	PA BLOOD VESSEL TUMOURS	PH 1.27 ANTIHYPERTENSIVES
	DAY 5	CLINICAL POSTING	Pelvic floor Anatomy and supports of uterus		PA 13.1, 13.3, 13.4 HEMATOPOIESIS, ANAEMIA (SGD)	PH 1.35 DRUGS USED IN ANEMIAS AND COLONY STIMULATING FACTORS	PH 1.35 DRUGS USED IN ANEMIAS AND COLONY STIMULATING FACTORS	INTEGRATED PATH AND PHYSIOLOGY
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.27 ANTIHYPERTENSIVES		PH 1.27 ANTIHYPERTENSIVES	MI 2.5 PERIPHERAL SMEAR EXAMINATION-MALARIA, FILARIA(SGD)	FM 1.4 JUVENILE JUSTICE BOARD,MAGISTRATE COURT	INTEGRATED MEDICINE
	DAY 2	CLINICAL POSTING	PA 14.1, 14.2 MICROCYTIC ANEMIA (SGD)		PA 14.1, 14.2 MICROCYTIC ANEMIA (SGD)	MI 2.4 AGENTS CAUSING ANEMIA	MI 1.2 AFB - DOAP	INTEGRATED WITH PATHOLOGY
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.19 ANTIDEPRESSANTS & ANXIOLYTICS	PA 15.1, 15.2 MACROCYTIC ANEMIA (SGD)	DOAP PATH PA 15.3 PERIPHERAL SMEAR MACROCYTIC ANEMIA
	DAY 4	CLINICAL POSTING	CM8.1 Epidemiology of Salmonellosis/Brucellosis		MI 4.1 ANAEROBIC INFECTIONS	PA 15.4 NON MEGALOBLASTIC MACROCYTIC ANEMIA (SDL)	PH 1.19 ANTIDEPRESSANTS & ANXIOLYTICS
	DAY 5	CLINICAL POSTING	MI 4.3 CULTURE IDENTIFICATION OF STAPHYLOCOCCUS AUREUS(SGD)		PA 16.1, 16.2, 16.5 HEMOLYTIC ANEMIA- DEFN, CLSSIFICATION, PATHO, C.F, INDICES, P.S	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT CVS	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT CVS
	DAY 6	CLINICAL POSTING	IA Pharmacology - CVS & Diuretics			AETCOM - 2.4 1. DEMONSTRATE RESPECT IN RELATIONSHIP WITH PATIENTS, FELLOW TEAM MEMBERS, SUPERIORS AND OTHER HEALTH CARE WORKERS
	DAY 7
	DAY 1	CLINICAL POSTING	PA 16.1, 16.2, 16.5 HEMOLYTIC ANEMIA- DEFN, CLSSIFICATION, PATHO, C.F, INDICES, P.S		PH 1.18 GENERAL ANAESTHETICS & PAM	MI3.1 GASTROINTESTINAL INFECTIVE SYNDROMES - LAB DIAGNOSIS	FM 1.5 COURT PROCEDURES-SUMMONS,CONDUCT MONEY	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	Su16.1 Minimal invasive surgery – advantage and disadvantage		PA 16.3 THALLASEMIA (SGD)	MI 4.3 SKIN AND SOFT TISSUE INFECTIONS- BACTERIA	MI 1.2 AFB - DOAP
	DAY 3	CLINICAL POSTING	CM8.1Epidemiology of Rickettsial disease -1		PH 1.18 GENERAL ANAESTHETICS & PAM	PA 16.3 SICKLE CELL ANEMIA (SGD)	DOAP PATH PA 16.6 PERIPHERAL SMEAR HEMOLYTIC ANEMIA
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Leishmaniasis / Hydatid disease		MI 8.2 OPPORTUNISTIC INFECTIONS(SGD)	PA 18.2 ACUTE LEUKEMIA (SGD)	PH 1.19 SEDATIVES & HYPNOTICS
	DAY 5	CLINICAL POSTING	Physiology of Ovulation		PA 18.2 ACUTE LEUKEMIA (SGD)	SGD PH 3.6 DEMONSTRATE HOW TO OPTIMIZE INTERACTION WITH PHARMACEUTICAL REPRESENTATIVE TO GET AUTHENTIC INFORMATION ON DRUGS	SGD PH 3.3 PERFORM A CRITICAL EVALUATION OF THE DRUG PROMOTIONAL LITERATURE
	DAY 6	CLINICAL POSTING	AET COM - Micro: Module 2.2 : Describe and discuss the role of non-maleficence as a guiding principle in patient care
	DAY 7
FIFTH MONTH	DAY 1	CLINICAL POSTING	PH 1.19 ANTI -EPILEPTICS		PH 1.19 ANTI -EPILEPTICS	MI 4.3 SKIN AND SOFT TISSUE INFECTIONS- VIRAL	FM 1.5 COURT PROCEDURES-TYPES OF WITNESSES,RECORDING OF OATH	INTEGRATED MEDICNE
	DAY 2	CLINICAL POSTING	PA 18.2 ACUTE LEUKEMIA (SGD)		PA 21.2, 21.3 PLATELET DISORDERS DIFF PLT & CLOTTING DISORDERS (SGD)	MI 4.3 CULTURE IDENTIFICATION OF PSEUDOMONAS(SGD)	MI 1.2 AFB - DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.19 OPIODS AGONISTS AND ANTAGONISTS	PA 21.2, 21.3 PLATELET DISORDERS DIFF PLT & CLOTTING DISORDERS (SGD)	DOAP PATH PA 19.7 SPLENOMEGALY
	DAY 4	CLINICAL POSTING	CM8.1Epidemiology of Rickettsial diseases -2		MI 4.3 SKIN AND SOFT TISSUE INFECTIONS- PARASITIC(SDL)	PA 16.4 ACQUIRED HEMOLYTIC ANEMIAS	PH 1.19 OPIODS AGONISTS AND ANTAGONISTS
	DAY 5	CLINICAL POSTING	Physiology of Menstruation		PA 21.2 VASCULAR DISORDERS (SGD)	SGD PH 2.2 OSPE-ORAL REHYDRATION SOLUTION PREPARATION	SGD PH 3.8 COMMUNICATE EFFECTIVELY WITH A PATIENT ON THE PROPER USE OF PRESCRIBED MEDICATION
	DAY 6	CLINICAL POSTING	AETCOM MODULE 2.7 IDENTIFY DISCUSS AND DEFINED, MEDIO LEGAL, SOCIO CULTURAL AND ETHICAL ISSUES AS THEY PERTAIN TO CONSENT FOR SURGICAL PROCEDURES
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.19 DRUGS FOR PARKINSONISM		SGD PH 1.19 DRUGS FOR NEURO DEGENERATIVE DISORDERS	MI 8.6 ANTIBIOGRAM	AUTOPSY CLASS-MAGISTRATE INQUIRY
	DAY 2	CLINICAL POSTING	PA 18.2 CHRONIC LEUKEMIAS (SGD)		PA 18.2 CHRONIC LEUKEMIAS (SGD)	MI 3.1 CULTURE IDENTIFICATION OF SALMONELLA TYPHI AND PARATYPHI B	MI 1.2 AFB - DOAP
	DAY 3	CLINICAL POSTING	CM8.1Epidemiology of Leprosy		SGD PH 1.20 EFFECTS OF ACUTE AND CHRONIC ALCOHOL INTAKE	PA MPD, THYMUS	DOAP PATH PA 20.1 PLASMA CELLMYELOMA
	DAY 4	CLINICAL POSTING	CM8.1 Epidemiology of Tetanus		MI 3.1 MICROBIAL AGENTS CAUSING DIARRHOEA	PA 19.1, 19.3 CAUSES AND DIFF FEATURES OF LYMPHADENOPATHY (SGD), TB LN	PH 1.21 SYMPTOMS AND MANAGEMENT OF METHANOL AND ETHANOL POISONING
	DAY 5	CLINICAL POSTING	MI 3.1 MICROBIAL AGENTS CAUSING DIARRHOEA (SGD)		PA 19.4 HODGKIN LYMPHOMA (SGD)	SGD PH 1.23 PROCESS AND MECHANISM OF DEADDICTION	SGD PH 5.1 COMMUNICATE WITH THE PATIENT WITH EMPATHY AND ETHICS ON ALL ASPECTS OF DRUG USE
	DAY 6	CLINICAL POSTING			SDL -FORENSIC MEDICINE-MEDICOLEGAL CERTIFCATION OF DEATH
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.19 ANTI -PSYCHOTICS & ANTI MANIAC DRUGS		PH 1.19 ANTI -PSYCHOTICS & ANTI MANIAC DRUGS	MI 3.1 MICROBIAL AGENTS CAUSING DIARRHOEA (SGD)	FM 1.5 COURT PROCEDURES-COURT QUESTIONS,RECORDNG OFEVIDENCE,CONDUCT OF DOCTOR IN WITNESS BOX	INTEGRATED MEDICNE
	DAY 2	CLINICAL POSTING	Su 17.4 pathophisiology and mechanism of head injuries.		PA 19.4 NON HODGKIN LYMPHOMA	MI 3.1 MICROBIAL AGENTS CAUSING DIARRHOEA - CHART DISCUSSION OF PARASITIC CYSTS AND OVA	MI 1.2 AFB-DOAP
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.19 ANTI -PSYCHOTICS & ANTI MANIAC DRUGS	PA 19.4 NON HODGKIN LYMPHOMA	DOAP PATH PA 19.5 HODGKIN LYMPHOMA
	DAY 4	CLINICAL POSTING	CM8.1 Epidemiology of AIDS		MI 3.2 MICROBIAL AGENTS CAUSING DYSENTRY(SGD)	PA ATELACTASIS, ACUTE LUNG INJURY	SDL - PH 1.33 DRUGS FOR COUGH (ANTI-TUSSIVES, EXPECTORANTS)
	DAY 5	CLINICAL POSTING	Anatomy of Fallopian tubes		PA 26.3 BRONCHIECTASIS, ASTHMA (SGD)	SGD - PH 1.32 DRUGS FOR BRONCHIAL ASTHMA & COPD	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT RS	INTEGRATED WITH PHARMACOLOGY
	DAY 6	CLINICAL POSTING	IA Pharmacology - CNS			AETCOM - 2.4 1. DEMONSTRATE RESPECT IN RELATIONSHIP WITH PATIENTS, FELLOW TEAM MEMBERS, SUPERIORS AND OTHER HEALTH CARE WORKERS
	DAY 7
	DAY 1	CLINICAL POSTING	PH1.37 INTRODUCTION TO HORMONES AND ANTERIOR PITUITARY HORMONES		PH1.37 INTRODUCTION TO HORMONES AND ANTERIOR PITUITARY HORMONES	MI 3.1 MICROBIAL AGENTS CAUSING DIARRHOEA - CHART DISCUSSION OF PARASITIC CYSTS AND OVA(SGD)	FM 1.6 COURT PROCEDURES-OFFENCES PERJURY
	DAY 2	CLINICAL POSTING	SU 17.5 neurological assessment & GCS in head injury		PA 26.1 PNEUMONIA (INTEGRATION)	MI 6.1 ETIOPATHOGENESIS, LAB DIAG AND PREVENTION OF INFECTION OF UPPER AND LOWER RESPIRATORY TRACT- BACTERIAL	MI 1.2 AFB - DOAP	INTEGRATED WITH MICRO
	DAY 3	CLINICAL POSTING	CM14.1 Hospital waste management		PH1.37 SEX HORMONES AND THEIR ANALOGUES - ANDROGENS / ANABOLIC STEROIDS	PA 26.3 COPD (SGD)	DOAP PATH 21.3 DIFF PLT FROM CLOTTING DISORDERS BASED ON CLINICAL AND HEMAT FEATURES
	DAY 4	CLINICAL POSTING	CM 14.2 Various methods of treatment of hospital waste		MI 6.1 ETIOPATHOGENESIS, LAB DIAG AND PREVENTION OF INFECTION OF UPPER AND LOWER RESPIRATORY TRACT- BACTERIAL	PA 26.5 OCCUPATIONAL LUNG DISEASES (SGD)	PH1.37 SEX HORMONES AND THEIR ANALOGUES - ESTROGEN / PROGESTERONES
	DAY 5	CLINICAL POSTING	PH 1.39 DRUGS USED IN CONTRACEPTION		PA DISEASES OF VASCULAR ORIGIN OF LUNG, LUNG TRANSPLANTATION	PH 1.39 DRUGS USED IN CONTRACEPTION	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT HORMONES	INTEGRATED OG
	DAY 6	CLINICAL POSTING	IA II - Microbiology / AETCOM module 2.2 describe and discuss the role of benefiscence of a guiding principle in patient care
	DAY 7
SIXTH MONTH	DAY 1	CLINICAL POSTING	PH 1.36 DRUGS FOR DIABETES MELLITUS		PH 1.36 DRUGS FOR DIABETES MELLITUS	MI 3.3 ENTERIC FEVER(SGD)	FM 1.7 DYING DECLARATION & DYING DEPOSITION	INTEGRATED MEDICINE
	DAY 2	CLINICAL POSTING	PA 26.6 TUMOURS OF LUNG (INTEGRATION)		PA 26.6 TUMOURS OF LUNG (INTEGRATION)	MI 3.4 DIAGNOSIS OF ENTERIC FEVER	MI 1.2 AFB-DOAP	INTEGRATED WITH MEDICINE
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.36 DRUGS FOR THYROID DISORDERS	PA 26.7 MESOTHELIOMA, PLEURAL DISEASES (SDL)	DOAP PATH 8.3 CYTOLOGYSTAINING
	DAY 4	CLINICAL POSTING	CM14.2 Hospital visit related to Hospital waste management		MI 3.5 CAUSATIVE AGENTS OF FOOD POISONING(SGD)	PA NON NEO LESIONS OF ORAL CAVITY, UPPER AIRWAYS, SALIVARY GLAND TUMORS, CONGENITAL ANAMOLIES OF GIT, ESOPHAGUS	PH 1.36 DRUGS FOR OSTEOPOROSIS
	DAY 5	CLINICAL POSTING	PH 1.41 UTERINE RELAXANTS AND STIMULANTS		PA 24.1 ORAL CANCERS (SDL)	SGD - PH 1.41 UTERINE RELAXANTS AND STIMULANTS	SGD PH 1.40 DRUGS USED IN THE TREATMENT OF INFERTILITY AND ERECTILE DYSFUNCTION	INTEGRATED OG
	DAY 6	CLINICAL POSTING	IA - PATH - 4			AETCOM MODULE 2.7 IDENTIFY DISCUSS AND DEFINED, MEDIO LEGAL, SOCIO CULTURAL AND ETHICAL ISSUES AS THEY PERTAIN TO CONSENT FOR SURGICAL PROCEDURES
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.38 CORTICOSTEROIDS		PH 1.38 CORTICOSTEROIDS	MI 3.5 CAUSATIVE AGENTS OF FOOD POISONING	FM 1.8 MEDICOLEGAL PRACTICE	INTEGRATED MEDICINE
	DAY 2	CLINICAL POSTING	PA 24.4 CA STOMACH (INTEGRATION)		PA 24.4 CA STOMACH (INTEGRATION)	MI 5.1 MENINGITIS CHART DISCUSSION RABIES	5.3 MICROBIAL AGENTS CAUSING MENINGITIS(SGD)	INTEGRATED WITH SURGERY
	DAY 3	CLINICAL POSTING	CM8.2 Non communicable diseases-INTRODUCTION		SGD - F182PH 1.34 ACID PEPTIC DISEASE, GERD	PA 24.2 PEPTIC ULCER	DOAP PATH PA 24.3 PEPTIC ULCER
	DAY 4	CLINICAL POSTING	CM8.2 Non communicable diseases-Epidemiology and control of Diabetes		MI 5.1MENINGITIS(SGD)	PA MALABSORPTION AND DIARRHOEA	PH 1.34 PROKINETICS, ANTIEMETICS
	DAY 5	CLINICAL POSTING	Puberty and changes after puberty		PA 24.6 INFLAMMATORY BOWEL DISEASES (SGD), APPENDIX PERITONEUM	PH 1.34 DRUGS FOR INFLAMMATORY BOWEL DISEASE, IRRITABLE BOWEL DISORDERS	PH 1.34 DRUGS FOR INFLAMMATORY BOWEL DISEASE, IRRITABLE BOWEL DISORDERS	INTEGRATED WITH PATH , SURGERY
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	MI 5.1 MENINGITIS		SGD PH 1.34 ANTIDIARRHOEALS & LAXATIVES	MI 5.1 MENINGITIS(SGD)	FM 1.9 IMPORTANCE OF DOCUMENTATION IN MEDICAL PRACTICE IN REGARD TO MEDICOLEGAL EXAMINATION	INTEGRATION WITH MEDICINE	INTEGRATION WITH RADIODIANOSIS,MEDICINE
	DAY 2	CLINICAL POSTING	PA 24.7 CA COLON, POLYPS OF INTESTINE AND STOMACH (INTEGRATION)		PA 24.7 CA COLON, POLYPS OF INTESTINE AND STOMACH (INTEGRATION)	MI 3.6 ACID PEPTIC DISEASE(SGD)	6.3 LRTI AGENTS & URTI agents (SGD)	INTEGRATED WITH SURGERY
	DAY 3	CLINICAL POSTING	PANDEMIC MODULE 2.5 - THERAPEUTIC STRATEGIES INCLUDING NEW DRUG DEVELOPMENT		PH 1.42 GENERAL PRINCIPLES OF CHEMOTHERAPY	PA 25. 1 JAUNDICE, BILIRUBIN METABOLISM	DOAP PATH PA 25.6 OBS VS NON OBS JAUNDICE
	DAY 4	CLINICAL POSTING	CM8.2 Epidemiology and control of cancers -1		MI 5.2 MICROBIAL AGENTS CAUSING ENCEPHALITIS	PA25.2, 25.5- HEPATIC FAILURE, PORTAL HT (SGD)	PH 1.42 GENERAL PRINCIPLES OF CHEMOTHERAPY
	DAY 5	CLINICAL POSTING	Fertilisation and implantation		PA 25.3 TOXIC HEPATITIS (SGD)	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT CNS	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT CNS
	DAY 6	CLINICAL POSTING	IA Pharmacology - AUTOCOIDS, RS, GIT			AETCOM - 2.8 DEMONSTRATE EMPATHY IN PATIENT ENCOUNTERS
	DAY 7
	DAY 1	CLINICAL POSTING	IM 19.1 MOVEMENT DISORDERS		PH 1.43 ANTIBIOTIC STEWARDSHIP PROGRAM - BETA LACTAM ANTIBIOTICS	MI 6.1 ETIOPATHOGENESIS, LAB DIAG AND PREVENTION OF INFECTION OF UPPER AND LOWER RESPIRATORY TRACT- BACTERIAL	FM 1.9 IMPORTANCE OF DOCUMENTATION IN MEDICAL PRACTICE IN REGARD TO MEDICOLEGAL EXAMINATION CONT..	INTEGRATED WITH MICRO
	DAY 2	CLINICAL POSTING	25.3 VIRAL HEPATITIS (INTEGRATION)		25.3 VIRAL HEPATITIS (INTEGRATION)	MI 3.7 VIRAL HEPATITIS - ETIOLOGY AND LAB DIAGNOSIS	MI 6.2 URTI AGENTS(SGD)	INTEGRATED WITH MEDICINE , MICRO
	DAY 3	CLINICAL POSTING	CM8.2Epidemiology and control of Stroke		PH 1.43 ANTIBIOTIC STEWARDSHIP PROGRAM - BETA LACTAM ANTIBIOTICS	PA 25.4 ALCOHOLIC LIVER DISEASE (SGD)	DOAP PATH PA 25.6 VIRAL HEPATITIS SEROLOGY PANEL
	DAY 4	CLINICAL POSTING	CM8.2 Epidemiology and control of cancers -2		MI 6.1 ETIOPATHOGENESIS, LAB DIAG AND PREVENTION OF INFECTION OF UPPER AND LOWER RESPIRATORY TRACT- PARASITIC	PA INTRA HEPATIC BILIARY TRACT DISEASE	PH 1.43 ANTIBIOTIC STEWARDSHIP PROGRAM - SULPHONAMIDES
	DAY 5	CLINICAL POSTING	MI 6.2 URTI AGENTS(SGD)		PA BILIARY TRACT- GALL STONES, CHOLECYSTITIS, CA GALL BLADDER	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT GIT	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT GIT
	DAY 6	CLINICAL POSTING	IA III - Microbiology / AETCOM module 2: describe and discuss the role of a physician in healthcare system
	DAY 7
SEVENTH MONTH	DAY 1	CLINICAL POSTING			PH 1.43 ANTIBIOTIC STEWARDSHIP PROGRAM - FLUROQUINOLONES	MI 1.2 STOOL EXAMINATION (DOAP)	IA -LEGAL PROCEDURE & MEDICAL JURISPRUDENCE	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	PA 32.6 PANCREATIC CANCER,NEURO ENDOCRINE TUMOURS (INTEGRATION)		PA 32.6 PANCREATIC CANCER,NEURO ENDOCRINE TUMOURS (INTEGRATION)	MI 8.3 ONCOGENIC VIRUSES-RNA(SDL)	MI 6.2 URTI AGENTS (SGD)	INTEGRATED WITH SURGERY
	DAY 3	CLINICAL POSTING	CM8.2 Epidemiology and control of RHD		PH 1.43 ANTIBIOTIC STEWARDSHIP PROGRAM - AMINOGLYCOSIDES	PA 28.1, 28.2 HISTOLOGY OF KIDNEY WITH INTRO TO RENAL FAILURE	DOAP PATH PA 23.3 TFT, RFT, LFT
	DAY 4	CLINICAL POSTING	CM8.2 Epidemiology and control of Blindness		MI 8.1 MICROBIAL AGENTS AND THEIR VECTORS CAUSING ZOONOTIC DISEASES	PA 28.5 GLOMERULONEPHRITIS (SGD)	PH 1.43 ANTIBIOTIC STEWARDSHIP PROGRAM - MACROLIDES AND MISCELLANEOUS ANTIBIOTICS
	DAY 5	CLINICAL POSTING	MI 6.1 ETIOPATHOGENESIS, LAB DIAG AND PREVENTION OF INFECTION OF UPPER AND LOWER RESPIRATORY TRACT- FUNGUS		PA 28.5 GLOMERULONEPHRITIS (SGD)	SGD PH 5.2 COMMUNICATE WITH THE PATIENT REGARDING OPTIMAL USE OF a)DRUG THERAPY, b)DEVICES AND c)STORAGE OF MEDICINES	SGD PH 5.2 COMMUNICATE WITH THE PATIENT REGARDING OPTIMAL USE OF a)DRUG THERAPY, b)DEVICES AND c)STORAGE OF MEDICINES
	DAY 6	CLINICAL POSTING	IA - PATH - 5			PA 28.7 GLOMERULAR MANIFESTATIONS OF SYSTEMIC DISEASES
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.44 ANTITUBERCULAR DRUGS		PH 1.44 ANTITUBERCULAR DRUGS	MDR & XDR TUBERCULOSIS	FM 1.9 MEDICAL CERTIFICATION OF DEATH	INTEGRATED WITH PHARMACOLOGY, MEDICINE
	DAY 2	CLINICAL POSTING	SU 22.1 Surgical Anatomy & physiology of thyroid		PA 28.5 GLOMERULONEPHRITIS (SGD)	MI 8.1 LAB DIAGNOSIS AND PREVENTION OF ZOONOTIC DISEASES (SGD)	6.3 LRTI AGENTS(SGD)
	DAY 3	CLINICAL POSTING	CM8.2 Epidemiology and control of Obesity		PH 1.45 DRUGS USED IN MDR AND XDR TB	PA 28.6 IG A NEPHROPATHY (SGD)	DOAP PATH PA 23.3 TFT, RFT, LFT
	DAY 4	CLINICAL POSTING	Cm8.2 Epidemiology and contol of Blindness		MI 4.3 SKIN AND SOFT TISSUE INFECTIONS- LEPROSY	PA 28.7 GLOMERULAR MANIFESTATIONS OF SYSTEMIC DISEASES	PH 1.46 ANTILEPROTIC DRUGS	INTEGRATED WITH PHARMACOLOGY
	DAY 5	CLINICAL POSTING	Embrygenesis and development of the fetus		PA 28.9 ATN (SGD)	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT ANTIBIOTICS	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT ANTIBIOTICS
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.55 ANTIMALARIAL DRUGS		PH 1.55 ANTIMALARIAL DRUGS	MI 8.2 OPPORTUNISTIC INFECTIONS(SGD)	FM 1.9 DOCUMENTS FOR ESTIMATION OF AGE BY PHYSICAL,DENTAL & RADIOLOGICAL EXAMINATION	INTEGRATED MEDICINE , MICRO, PATHOLOGY
	DAY 2	CLINICAL POSTING	PA 28.8 DISEASES AFFECTING TUBULAR INTERISTITIUM (SGD)		PA 28.8 DISEASES AFFECTING TUBULAR INTERISTITIUM (SGD)	MI 7.3 URINARY TRACT INFECTIONS(SGD)	MI 2.6PERIPHERAL SMEAR - PLASMODIUM (DOAP)	INTEGRATED WITH PATHOLOGY
	DAY 3	CLINICAL POSTING	CM8.2 Epidemiology and control of Accidents		PH 1.47 TREATMENT OF KALA AZAR	PA 28.10 ACUTE AND CHRONIC PYELONEPHRITIS (SGD)	PA 23.1 URINE EXAMINATION
	DAY 4	CLINICAL POSTING	CM8.2 Epidemiology and control of Injuries		MI 8.3 ONCOGENIC VIRUSES- DNA(SDL)	PA 28.11 VASCULAR DISEASES OF KIDNEY	PH 1.47 TREATMENT OF AMOEBIASIS
	DAY 5	CLINICAL POSTING	MI 8.4 EMERGING REEMERGING INFECTIONS		PA 28.12 CYSTIC DISEASES OF KIDNEY (SGD)	SGD PH 5.3 MOTIVATE PATIENTS WITH CHRONIC DISEASES TO ADHERE TO THE PRESCRIBED MANAGEMENT BY THE HEALTH CARE PROVIDER	SGD PH 5.3 MOTIVATE PATIENTS WITH CHRONIC DISEASES TO ADHERE TO THE PRESCRIBED MANAGEMENT BY THE HEALTH CARE PROVIDER
	DAY 6	CLINICAL POSTING	IA - Pharmacology - HORMONES			AETCOM - 2.8 DEMONSTRATE EMPATHY IN PATIENT ENCOUNTERS
	DAY 7
	DAY 1	CLINICAL POSTING	IM 19.9 MOVEMENT DISORDERS		PH 1.47 TREATMENT OF HELMINTHIC INFECTIONS	MI 2.5 KALA AZAR, MALARIA, AMEBIASIS, INTESTINAL HELMINTHS	FM 1.10 CAUSE OF DEATH IN PARTICULAR SCENARIO BY ICD 10 CODE	INTEGRATED WITH PHARMACOLOGY
	DAY 2	CLINICAL POSTING	SU 22.2 Etiopathogenesis of thyroid swelling		PA 28.13 URINARY TRACT CALCULI & OBSTRUCTIVE UROPATHY (SGD)	MI 8.2 CULTURE IDENTIFICATION OF ASPERGILLUS SPECIES	MI 2.6 FILARIA(DOAP)
	DAY 3	CLINICAL POSTING	CM8.2 Epidemiology and control of Cardiovascular diseases		SGD - PH 1.47 TREATMENT OF HELMINTHIC INFECTIONS	PA 28.14 RENAL TUMOURS (SGD)	DOAP PATH PA 23.1 URINE EXAMINATION
	DAY 4	CLINICAL POSTING	CM8.2 Epidemiology and control of Oral diseases		MI 8.5 HEALTH CARE ASSOCIATED INFECTIONS(SGD)	PA URETER, BLADDER, URETHRA	PH 1.48 ANTIVIRAL DRUGS - INTRODUCTION AND DRUGS FOR HEPATITIS
	DAY 5	CLINICAL POSTING	PH 1.48 DRUGS FOR UTI AND STD		PA 28.16 UROTHELIAL TUMOURS	PH 1.48 DRUGS FOR UTI AND STD	SGD PH 5.4 EXPLAIN TO THE PATIENT THE RELATIONSHIP BETWEEN COST OF TREATMENT AND PATIENT COMPLIANCE	INTEGRATED OG
	DAY 6	CLINICAL POSTING	IA IV Microbiology / AETCOM module 2.2: describe and discuss the role of justice as a guiding principle in patient care
	DAY 7
EIGHT MONTH	DAY 1	CLINICAL POSTING	IM 15.1 GI BLEEDING		PH 1.48 ANTI INFLUENZA DRUGS	MI ETIOPATHOGENESIS, LAB DIAG AND PREVENTION OF INFECTION OF UPPER AND LOWER RESPIRATORY TRACT- VIRAL	FM 1.10 CASE SCENARIO DISCUSSION	INTEGRATED WITH PHARMACOLOGY
	DAY 2	CLINICAL POSTING	SU 22.3 clinical examination of thyroid & differential diagnosis		PA 8.1 DIAGNOSTIC ROLE OF CYTOLOGY AND ITS APPLICATION IN CLINICAL CARE (SGD)	MI 8.5 SURGICAL SITE NFECTIONS	MI - Rapid Diagnostic Tests (DOAP)
	DAY 3	CLINICAL POSTING	CM8.2 Epidemiology and control of Coronary artery disease		PH 1.48 ANTIVIRAL DRUGS - INTRODUCTION	PA 29.1 TESTICULAR TUMOURS (SGD)	DOAP PATH 8.3 CYTOLOGYSTAINING
	DAY 4	CLINICAL POSTING	CM8.3 NPCDCS-1		MI 8.6 INFECTION CONTROL(SGD)	PA 29.1 TESTICULAR TUMOURS (SGD)	PH 1.48 DRUGS FOR HEPATITIS
	DAY 5	CLINICAL POSTING	Anatomy and development of the placenta		PA 29.3 BPH (SDL)	PH 1.48 DRUGS FOR HIV	PH 1.48 DRUGS FOR HIV	INTEGRATION MICRO MEDICINE
	DAY 6	CLINICAL POSTING	IA - PATH - 6			PA 8.1 DIAGNOSTIC ROLE OF CYTOLOGY AND ITS APPLICATION IN CLINICAL CARE
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.49 ANTI CANCER DRUGS		PH 1.49 ANTI CANCER DRUGS	MI 8.7 PERSONAL PROTECTIVE EQUIPMENTS - DONNING DOFFING TECHNIQUE	FM 1.11 CAUSE OF DEATH CERTIFICATE PER ICD 10 DOCUMENT	INTEGRATION MEDICINE
	DAY 2	CLINICAL POSTING	PA 29.4, 29.5 CA PROSTATE, PROSTITIS (INTEGRATION)		PA 29.4, 29.5 CA PROSTATE, PROSTITIS (INTEGRATION)	MI 8.7 PERSONAL PROTECTIVE EQUIPMENTS(SGD)	MI8.15 Rapid Diagnostic Tests (DOAP)	INTEGRATED WITH SURGERY
	DAY 3	CLINICAL POSTING	CM8.3 NPCDCS -2		PH 1.49 ANTI CANCER DRUGS	PA 30.6 CERVICITIS AND PRECURSOR LESIONS(SGD)	DOAP PATH PA 23.3 SEMEN ANALYSIS
	DAY 4	CLINICAL POSTING	CM 8.2 Small group discussion on primodial prevention of NCDs		MI 8.6 INFECTION CONTROL(SGD)	PA 30.1 CA CERVIX (SGD)	PH 1.49 ANTI CANCER DRUGS
	DAY 5	CLINICAL POSTING	Maternal changes in pregnancy		PA 30.7, 30.8 ENDOMETRIOSIS, ADENOMYOSIS (SGD), VULVA, VAGINA, FALLOPIAN TUBE	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT ANTIVIRAL/ANTIPROTOZOAL DRUGS	SGD PH 3.1, 3.2 PRESCRIPTION WRITING / AUDIT ANTIVIRAL/ANTIPROTOZOAL DRUGS
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 16.1 DIARRHOEAL DISORDER		PH 1.57 DRUGS USED IN SKIN DISORDERS (SDL) - ANTI FUNGAL	MI 4.3 SKIN AND SOFT TISSUE INFECTIONS-FUNGAL	AUTOPSY CLASS-SUDDEN DEATH	INTEGRATED WITH PHARMACOLOGY
	DAY 2	CLINICAL POSTING	PA 30.9 ENDOMETRIAL HYPERPLASIA PA 30.2 CA ENDOMETRIUM (INTEGRATION)		PA 30.9 ENDOMETRIAL HYPERPLASIA PA 30.2 CA ENDOMETRIUM (INTEGRATION)	MI 8.8 BACTERIOLOGY OF WATER(SGD)	MI8.15 Rapid Diagnostic Tests (DOAP)	INTEGRATION WITH OG
	DAY 3	CLINICAL POSTING	CM15.1 Mental health		PH 1.57 DRUGS USED IN SKIN DISORDERS (SDL)	PA 30.3 LEIOMYOMA, LEIOMYOSARCOMA(SGD)	DOAP PATH 8.3 CYTOLOGYSTAINING
	DAY 4	CLINICAL POSTING	CM15.2Mental health-Warning signs		MI 8.8 BACTERIOLOGY OF MILK(SDL)	PA 30.5 GTD (SGD)	SGD PH 1.22 DRUGS OF ABUSE (SGD)
	DAY 5	CLINICAL POSTING	PA 30.4 NEOPLASTIC LESIONS OF OVARY (INTEGRATION)		PA 30.4 NEOPLASTIC LESIONS OF OVARY (INTEGRATION)	SGD PH 5.5 LINE OF MANAGEMENT ON DRUG DEPENDENCE	SGD PH 5.6 DEMONSTRATE ABILITY TO EDUCATE PUBLIC AND PATIENTS ABOUT VARIOUS ASPECTS OF DRUG USE INCLUDING DRUG DEPENDENCE AND OVER THE COUNTER DRUGS	INTEGRATED WITH OG
	DAY 6	CLINICAL POSTING	IA - Pharmacology - ANTIBACTERIAL, ANTIFUNGAL, ANTIHELMINTHIC DRUGS			AETCOM - 2.8 DEMONSTRATE EMPATHY IN PATIENT ENCOUNTERS
	DAY 7
	DAY 1	CLINICAL POSTING	PH 1.43 RATIONAL USE OF ANTIMICROBIALS		PH 1.43 RATIONAL USE OF ANTIMICROBIALS	MI 8.8 BACTERIOLOGY OF AIR (SDL)	FM 2.1 FORENSIC PATHOLOGY-TYPES OF DEATH	INTEGRATED MEDICINE
	DAY 2	CLINICAL POSTING	PA 31.1, 31.4 BENIGN BREAST DISEASE, BREAST PA 31.2 CA BREAST (INTEGRATION)		PA 31.1, 31.4 BENIGN BREAST DISEASE, BREAST PA 31.2 CA BREAST (INTEGRATION)	MI 8.9 venepuncture technique(DOAP)	MI 1.2 GRAMS STAINREVISION(DOAP)	INTEGRATED WITH SURGERY
	DAY 3	CLINICAL POSTING	CM15.3 National mental health program -Lecture		PH 1.59 ESSENTIAL MEDICINES	PA ENDOCRINE- PITUITARY	DOAP PATH PA 31.3 CA BREAST
	DAY 4	CLINICAL POSTING	CM15.3 National mental health program -Group discussion		MI 2.3 Blood Collection(DOAP)	PA 32.3 HYPOTHYROIDISM THYROIDITIS(SGD)	SGD - PH 1.59 HERBAL MEDICINES
	DAY 5	CLINICAL POSTING	Diagnosis of pregnancy		PA 32.2 THYROTOXICOSIS GRAVES, GOITRE (SGD)	SGD PH 5.7 LEGAL AND ETHICAL ASPECTS OF PRESCRIBING DRUGS	SGD PH 5.7 LEGAL AND ETHICAL ASPECTS OF PRESCRIBING DRUGS
	DAY 6	CLINICAL POSTING	IA V /AETCOM module 2.3 describe and discuss the role of justice as aguiding principle in patient care
	DAY 7
	DAY 1	CLINICAL POSTING	IM 6.1 HIV		SDL - PH 1.59 FIXED DOSE COMBINATIONS	MI 8.15 MOLECULAR DIAGNOSIS(SGD)	FM 2.1 FORENSIC PATHOLOGY-BRAIN DEATH,CORTICAL DEATH,BRAINSTEM DAETH	INTEGRATION WITH PATHOLOGY
	DAY 2	CLINICAL POSTING	SU22.4 clinical features, classification & management of CA thyroid		PA 32.5 PARATHYROID (SGD)	MI 8.10SAMPLE COLLECTION(SGD)	MI1.2-AFB STAIN REVISION(DOAP)
	DAY 3	CLINICAL POSTING	CM15.3 National mental health program -Group discussion		SDL - PH 1.59 OVER THE COUNTER DRUGS	PA 32.4 DIABETES MELLITUS (SGD)	DOAP PATH 8.3 CYTOLOGYSTAINING
	DAY 4	CLINICAL POSTING	CM 13.1 Field visit on related to mental health		MI 8.10 SAMPLE COLLECTION(SGD)	PA 32.4 DIABETES MELLITUS (SGD)	PH 1.54 VACCINES AND THEIR USES
	DAY 5	CLINICAL POSTING	MI 8.6 BIOMEDICAL WASTE MANAGEMENT		PA 32.9 ADRENAL NEOPLASMS	DOAP - PH 4.2 DEMOSTRATE THE EFFECTS OF DRUGS ON BLOOD PRESSURE (VASOPRESSOR AND VASODEPRESSORS WITH APPROPRIATE BLOCKERS) USING COMPUTER AIDED LEARNING	DOAP - PH 4.2 DEMOSTRATE THE EFFECTS OF DRUGS ON BLOOD PRESSURE (VASOPRESSOR AND VASODEPRESSORS WITH APPROPRIATE BLOCKERS) USING COMPUTER AIDED LEARNING
	DAY 6	CLINICAL POSTING			SEMINAR -FORENSIC MEDICINE
	DAY 7
NINENTH MONTH	DAY 1	CLINICAL POSTING	IM 11.1 DIABETES MELLITUS		PH 1.55 NATIONAL HEALTH PROGRAMMES	MI 1.1 LAB DIAGNOSIS OF VIRAL INFECTIONS(SGD)	FM 2.2 NATURAL & UNNATURAL DEATHS	INTEGARTION WITH PATOLOGY
	DAY 2	CLINICAL POSTING	Su 22.5 applied anatomy of parathyroid		PA 32.7 ADRENAL INSUFFICIENCY	MI 8.12 CONFIDENTIALITY PERTAINING TO PATIENT IDENTITY IN LABORATORY RESULTS(SGD)	MI 8.15 LAB DIAGNOSIS OF VIRAL INFECTIONS(SGD)
	DAY 3	CLINICAL POSTING	CM18.1International Health-1		SGD - PH 1.55 NATIONAL HEALTH PROGRAMMES	PA 32.8 CUSHINGS SYNDROME (SGD)	DOAP PATH 8.3 CYTOLOGYSTAINING
	DAY 4	CLINICAL POSTING	CM18.2 International Health -2		MI 8.10 LAB DIAGNOSIS OF VIRAL INFECTIONS(SGD)	PA MEN SYNDROMES, PINEAL GLAND(SDL)	PH 1.56 BASICS OF GERIATRIC PHARMACOLOGY
	DAY 5	CLINICAL POSTING	MI 8.10 LAB DIAGNOSIS OF VIRAL INFECTIONS(SGD)		PA DEVELOPMENTAL ABNORMALITIES, OSTEOPOROSIS, FRACTURES	DOAP - PH 4.2 DEMOSTRATE THE EFFECTS OF DRUGS ON BLOOD PRESSURE (VASOPRESSOR AND VASODEPRESSORS WITH APPROPRIATE BLOCKERS) USING COMPUTER AIDED LEARNING	DOAP - PH 4.2 DEMOSTRATE THE EFFECTS OF DRUGS ON BLOOD PRESSURE (VASOPRESSOR AND VASODEPRESSORS WITH APPROPRIATE BLOCKERS) USING COMPUTER AIDED LEARNING
	DAY 6	CLINICAL POSTING	IA - PATH - 7			PA DEVELOPMENTAL ABNORMALITIES, OSTEOPOROSIS, FRACTURES
	DAY 7
	DAY 1	CLINICAL POSTING			SGD - PH 1.62 ANTISEPTICS AND DISINFECTANTS	MI 8.13 CHOOSE APPROPRIATE LABORATORY TEST IN THE DIAGNOSIS OF INFECTIVE DISEASES	FM 2.2 SUDDEN NATURAL DEATHS	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	PA 33.1,33.2 OSTEOMYELITIS, BONE TUMORS (SGD)		PA 33.1,33.2 OSTEOMYELITIS, BONE TUMORS (SGD)	MI 7.1 SEXUALLY TRANSMITTED INFECTIONS REVISION	MI 8.15 INTERPRETATION OF LABORATORY RESULTS(SGD)
	DAY 3	CLINICAL POSTING	CM10.9 Gender and health- Lecture		SGD - PH 1.61 DIETARY SUPPLEMENTS AND NEUTRACEUTICALS	PA 33.4 PAGET DISEASE (SGD)	PA 33.5 RHEUMATOID ARTHRITIS (SGD)
	DAY 4	CLINICAL POSTING	CM10.9 Gender and health- Group discussion		MI 8.15 OCULAR AND EAR INFECTIONS (SDL)	DOAP PA 23.2 BODY FLUIDS EXAMINATION	PH 1.16 5 ANTI - RHEUMATOID DRUGS & DRUGS FOR GOUT
	DAY 5	CLINICAL POSTING	Antenatal care and high risk obstetrics		PA SERONEGATIVE ARTHROPATHIES, TUMOR AND TUMOR LIKE CONDITIONS OF JOINTS	DOAP - PH 2.3 SETTING UP OF INTRAVENOUS DRIP IN A SIMULATED ENVIRONMENT	DOAP - PH 2.3 SETTING UP OF INTRAVENOUS DRIP IN A SIMULATED ENVIRONMENT
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	MI3.1 GASTROINTESTINAL INFECTIVE SYNDROMES		PH 1.50 IMMUNOMODULATORS	MI 8.15 INTERPRETATION OF LABORATORY RESULTS(SGD)	FM 2.4 ORGAN TRANSPLANTATION & HUMAN ORGAN TRANSPLANT (AMENDMENT) ACT 2011(AETCOM)	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	Su 25.1 applied anatomy & investigations for breast disease		PA33.3 SOFT TISSUE TUMOURS (SGD)	MI 8.16 NATIONAL HEALTH PROGRAM	MI 1.1/8.15 IDENTIFICATIONOF BACTERIA - REVISION(SGD)
	DAY 3	CLINICAL POSTING	CM10.8 Adolescent reproductive sexual health -		PH 1.50 IMMUNOSUPPRESSIVE THERAPY	PA NON NEOPLASTIC LESIONS OF SKIN(SDL)	DOAP PATH PA 34.4 TUMOURS OF SKIN
	DAY 4	CLINICAL POSTING	CM10.9 Gender issues and women empowerment		MI 8.15 INTERPRETATION OF LABORATORY RESULTS(SGD)	PA BENIGN AND PREMALIGNANT LESIONS OF SKIN	PH 1.51 OCCUPATIONAL AND ENVIRONMENTAL PESTICIDES , FOOD ADULTERANTS, POLLUTANTS
	DAY 5	CLINICAL POSTING	Assesment of fetal growth		PA 34.1 34.2 34.3 SCC , BCC, MELANOMA (SGD)	SGD PH 3.7 PREPARE LIST OF ESSENTIAL MEDICINES FOR A HEALTH CARE FACILITY	SGD PH 3.7 PREPARE LIST OF ESSENTIAL MEDICINES FOR A HEALTH CARE FACILITY
	DAY 6	CLINICAL POSTING	IA - CHEMOTHERAPY - ANTIVIRAL, ANTICANCER DRUGS			AT COM Module - 2.1, DEMONSTRATE ABILITY TO COMMUNICATE TO PATIENT IN A PATIENT, RESPECTFUL, NON THREATENING, NON JUDGEMENTAL AND EMPATHETIC MANNER
	DAY 7
	DAY 1	CLINICAL POSTING			PH 1.53 HEAVY METALS AND CHELATING AGENTS (SDL)	MI 3.6 ACID PEPTIC DISEASE	FM 2.4 ORGAN TRANSPLANTATION & HUMAN ORGAN TRANSPLANT (AMENDMENT) ACT 2011(AETCOM) CONT..	INTEGRATED WITH MEDICINE
	DAY 2	CLINICAL POSTING	Su 25.3 clinical features investigations & treatment of breast disease		PA CNS DEVELOPMENTAL DISEASES, INJURY	MI 8.1 ZOONOTIC INFECTIONS(SDL)	MI1.6 ANTIMICROBIAL SUSCEPTIBILITY TEST - REVISION(SGD)
	DAY 3	CLINICAL POSTING	CM8.1Epidemiology of Emerging and Re - emerging Infections		SGD - PH 1.52 - DESCRIBE MANAGEMENT OF COMMON POISONING, INSECTICIDE, COMMON STINGS AND BITES	PA CNS EDEMA, ICT, MALFORMATIONS	DOAP PATH 35.3 ETIOLOGY OF MENINGITIS BASED ON CSF FINDINGS
	DAY 4	CLINICAL POSTING	CM10.8 Adolescent reproductive sexual health - GD		MI 8.1 COMMON VECTORS CAUSING ZOONOTIC DISEASES	PA PRION DISEASES	PH 1.13, 1.14 - ANS SGD
	DAY 5	CLINICAL POSTING	Teratogenesis		PA DEMYELINATING DISEASES OF CNS, DEGENERATIVE DISEASES OF CNS	SGD PH 2.2 OSPE-REVISON	SGD PH 2.2 OSPE-REVISON
	DAY 6	CLINICAL POSTING	IA VI / AETCOM module 2.3 describe and discuss the role of justice as aguiding principle in patient care
	DAY 7
TENTH MONTH	DAY 1	CLINICAL POSTING	IM 12.1 THYROID DYSFUNTION		PH 1.13, 1.14 - ANS SGD	MI 2.3 BLOOD STREAM INFECTIONS REVISION(SGD)	FM 2.5 MODES OF DEATH,COMA,ASPHYXIA & SYNCOPE
	DAY 2	CLINICAL POSTING	SU 28.3 clinical features complications & principles of management of peritonitis		PA METABOLIC DISEASES OF BRAIN- GENETIC, TOXIC & ACQUIRED	MI 1.5 APPROPRIATE METHOD OF STERILISATION AND DISINFECTION IN SPECIAL SITUATIONS REVISION (SGD)	MI 1.1/8.15 LAB DIAGNOSIS OF FUNGAL INFECTIONS -REVISION(SGD)
	DAY 3	CLINICAL POSTING	CM8.1 Programmes related to control of STD		PH 1.19 CNS - SGD	PA 35.2 CNS TUMOURS	DOAP PA 8.2 BASICS OF EXFOLIATIVE CYTOLOGY- TECHNIQUE AND STAINS USED
	DAY 4	CLINICAL POSTING	CM8.1 Bioterrorism -AGENTS and control		MI 1.9 VACCINES	PA CEREBROVASCULAR DISEASES	PH 1.19 CNS - SGD
	DAY 5	CLINICAL POSTING	USG in pregnancy		PA 22.1 ABO & RH GROUPING PA 22.6 TRANSFUSION REACTIONS (SGD)	PH 2.1 ,2.4 DRUG DOSAGE REVISION	PH 2.1 ,2.4 DRUG DOSAGE REVISION
	DAY 6	CLINICAL POSTING	IA - PATH - 8			PA 22.1 ABO & RH GROUPING PA 22.6 TRANSFUSION REACTIONS (SGD)
	DAY 7
	DAY 1	CLINICAL POSTING	IM 10.1 AKI AND CKD		PH 1.18,1.21 CNS - SGD	MI 1.1,1.2,1.6,8.10 GENERAL BACTERIOLOGY REVISION	FM 2.6 PRRSUMPTION OF DEATH,SURVIVORSHIP
	DAY 2	CLINICAL POSTING	SU 30.5 clinical features investigations & treatment of hydrocele		PA 22.1 ABO & RH GROUPING PA 22.6 TRANSFUSION REACTIONS (SGD)	MI8.15IMMULOLOGY REVISION	MI 6.3 LAB DIAGNOSIS OF TUBERCULOSIS(SGD)
	DAY 3	CLINICAL POSTING	CM8.1 AIDS -lecture		PH 1.26, 1.27,1.28 CVS - SGD	MI8.15IMMULOLOGY REVISION	DOAP PATH PRACTICALS REVISION
	DAY 4	CLINICAL POSTING	CM8.1 Hytadid disease		MI2.7, 8.15, 8.16 VIRAL INFECTIONS REVISION	PA 22.5 INFECTIONS TRANSMITED BY TRANSFUSION	PH 1.26, 1.27,1.28 CVS - SGD
	DAY 5	CLINICAL POSTING	Maternal pelvis		PA 36.1 RETINOBLASTOMA	SGD PH 3.1 , 3.2 PRESCRIPTION WRITING / AUDIT REVISION	SGD PH 3.1 , 3.2 PRESCRIPTION WRITING / AUDIT REVISION
	DAY 6	CLINICAL POSTING			II SATURDAY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 13.1 COMMON MALIGNANCY		PH 1.26, 1.27,1.28 CVS - SGD	MI 8.15MYCOLOGY CULTURE DISCUSSION (SGD)	FM 2.7 SUSPENDED ANIMATION
	DAY 2	CLINICAL POSTING	SU 28.7 applied anatomy & Pathophysiology of stomach		REVISION GENERAL PATHOLOGY	MI 8.5,8.6, HOSPITAL INFECTION CONTROL REVISION - REVISION(SGD)	IMMNOSEROLOGY REVISION(SGD)
	DAY 3	CLINICAL POSTING	CM8.1 Demonstration session on ORS		PH 1.36, 1.37, 1.39, 1.40 HORMONES - SGD	REVISION GENERAL PATHOLOGY	DOAP PATH PRACTICALS REVISION
	DAY 4	CLINICAL POSTING	CM8.2 Field visit -RNTCP unit		MI8.7, 8.8HOSPITAL INFECTION CONTROL REVISION - REVISION(SGD)	REVISION GENERAL PATHOLOGY	PH 1.36, 1.37, 1.39, 1.40 HORMONES - SGD
	DAY 5	CLINICAL POSTING	Fetal skull		REVISION RBC WBC WITH DOAP SESSION	DOAP - PH 4.1 ADMINISTER DRUGS THROUGH VARIOUS ROUTES IN A SIMULATED ENVIRONMENT USING MANNEQUINES - REVISION	SGD PH 4.2 CAL REVISION
	DAY 6	CLINICAL POSTING		IA - PHARMACOLOGY MODEL REVISION - THEORY
	DAY 7
	DAY 1	CLINICAL POSTING	IM 21.1 POISONING		PH 1.43, 1.46 , 1.47, 1.48 - CHEMOTHERAPY SGD	IA - Microbiology - Model Practicals
	DAY 2	CLINICAL POSTING	Su 28.1 pathophysiology clinical features investigations & management of hernia		REVISION SYSTAMIC PATHOLOGY	MI1.1,8.15 FUNGAL INFECTIONS REVISION(SGD)
	DAY 3	CLINICAL POSTING	CM8.1 DOAP Session on ARI		PH 1.43, 1.46 , 1.47, 1.48 - CHEMOTHERAPY SGD
	DAY 4	CLINICAL POSTING	CM8.1 Small group discussion on TB		MI3.1,3.2,8.15 PARASITIC INFECTIONSREVISION(SGD)	REVISION SYSTAMIC PATHOLOGY	PH 1.43, 1.46 , 1.47, 1.48 - CHEMOTHERAPY SGD
	DAY 5	CLINICAL POSTING	Fetal circulation		PRACTICAL REVISION	IA - PHARMACOLOGY MODEL REVISION - PRACTICALS
	DAY 6	CLINICAL POSTING			IA - Microbiology - Model Theory
	DAY 7

Date	Days	8-9am	9- 10 am	10-11am	11.15am - 12.15pm	12.15pm - 1.15	Lunch 1.15-2.00	2.00pm - 3.00pm	03.00pm - 04.00pm
16.12.23	Saturday	orientation	orientation	orientation	orientation	orientation	orientation	orientation	orientation
18.12.23	Monday	orientation	orientation	orientation	orientation	orientation	orientation	orientation	orientation
19-12-23	Tuesday	CP	CP	CP	PH 1.1 Principles of Pharmacology Pharmacotherapeutics (L1)	PA 1.1,1.2,1.3 INTRODUCTION TO PATHOLOGY -L	LUNCH	MI 1.1 Introduction to Microbiology	MI 1.1 Morphology of bacteria
20-12-23	Wednesday	CP	CP	CP	CM8.1,8.2,8.3 RABIES(L)	CM8.1,8.2,8.3 RABIES(L)		PA 2.1- CELL INJURY-L	PA 2.1 CELL INJURY-L
21-12-23	Thursday	CP	CP	CP	PA 2.4 CELL DEATH NECROSIS -SGD	MI 1.1Microscopy	LUNCH	PH 1.4 PK-Absorption, Distribution (L1)	INTRODUCTION -PRACTICAL CLASS
22-12-23	Friday	CP	CP	CP	PH 1.4 PK-Absorption, Distribution (L1)	PH 1.3 Drug Formulations DDS (L1)		PA 2.4,2.7-APOPTOSIS-SGD	PRACTICALS- MICROSCOPY
23-12-23	Saturday	AETCOM -MODULE 2.1 medicine	OG 2.1 Development and Anatomy of Female Reproductive Tract	FM1.1 FM1.2 Introduction to Forensic Medicine and Toxicology	MI1.1 Physiology of bacteria	MI 1.1 SPECIMEN COLLECTION AND TRANSPORT	LUNCH	PH 2.5 AETCOM-Bio Ethics	PH2.5 AETCOM- Bio Ethics
24-12-23	Sunday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
25-12-23	Monday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
26-12-23	Tuesday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
27-12-23	Wednesday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
28-12-23	Thursday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
29-12-23	Friday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
30-12-23	Saturday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
31-12-23	Sunday	vacation	vacation	vacation	vacation	vacation	vacation	vacation	vacation
01-01-24	Monday			holiday
02-01-24	Tuesday	CP	CP	CP	PH 1.4 PK Biotransformation (L1)	PA 2.2- Mechanism of Cell injury-SGD	Lunch	MI 1.2 Staining techniques in detection of organisms	MI 1.1 Culture media
03-01-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4 HIV/AIDS(L)	CM 8.1,8.3,8.4 HIV/AIDS(L)		Pathological calcification - PA2.5-L	Cell as a unit of health /disease-SDL
04-01-24	Thursday	CP	CP	CP	PA 2.3 Intracellular accumulation-SGD	MI 1.1 Culture methods	LUNCH	PH 1.4 PK – Excretion (L1)	PATH PRACTICALS 4.4- ACUTE INFLAMMATION & cHRONIC INFLAMMATION -DOAP
05-01-24	Friday	CP	CP	CP	PH 1.5 Pharmacodynamics (L1)	PH 1.5 Pharmacodynamics (L1)		PA 2.5,2.7-Gangrene, cell ageing -SGD	PRACTICALS MICRO 1.2 GRAM STAINING
06-01-24	Saturday	yoga	SU1.1 Describe Basic concepts of homeostasis, enumerate the metabolic changes in injury and their mediators.	FM1.3 FM1.4 Legal Procedures 1	PA 2.6-CELLULAR ADAPTATIONS-SGD	PH 1.3Dosage Formulations		PH 2.5 AETCOM- Bioethics	PH 2.5 AETCOM- Bioethics
07-01-24	Sunday			holiday
08-01-24	Monday	CP	CP	CP	OG 3.1 Physiology of Ovulation, Menstruation, Fertilization, Implantation and Gametogenesis.	MI 1.1 Identification of Bacteria		PH 2.1 Drug Formulations DDS (SGD/Practical1)	PH 2.1 Drug Formulations DDS (SGD/Practical1)
09-01-24	Tuesday	CP	CP	CP	PH 1.9 Nomenclature of drugs(L1)	PA 4.1 ACUTE AND CHRONIC INFLAMMATION /EVENTS OF INFLAMMATION-L	Lunch	MI 1.1 Antimicrobial susceptibility testing	MI 1.1 Bacterial genetics
10-01-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4 RICKETSSIAL INFECTIONS (L)	FM1.5 Legal Procedures 2	LUNCH	PA 4.2- MEDIATORS OF INFLAMMATION-SGD	PA 4.2, MEDIATORS OF INFLAMMATION-SGD
11-01-24	Thursday	CP	CP	CP	PA 4.3- Chronic inflammation -SGD	MI 1.1 Overview of Bacterial Infections		PH 1.56 Pediatric & Geriatric Pharmacology (L1)	PRACTICAL PATHOLOGY-INTRODUCTION
12-01-24	Friday	CP	CP	CP	PH 1.12 Dosage calculations children, elderly, Renal,Hepatic dysfunction (SGD1/Theory)	PH 1.12 Dosage calculations children, elderly, Renal,Hepatic dysfunction (SGD1/Theory)		PA 5.1 Tissue repair- L	PRACTICALS MICRO 1.2 GRAM STAINING
13-01-24	Saturday			holiday
14-01-24	Sunday			holiday
15-01-24	Monday			holiday
16-01-24	Tuesday			holiday
17-01-24	Wednesday			holiday
18-01-24	Thursday	CP	CP	CP	PA 5.1-Wound healing-SGD	MI 1.1 Introduction to Virology	LUNCH	1.63 Drug Regulations/ Drug Development & GCP ( L1)	PERIPHERAL SMEAR -PRACTICAL
19-01-24	Friday	CP	CP	CP	PH 1.6 Pharmacovigilance & ADR reporting Systems (L1)	PH 1.6 Pharmacovigilance & ADR reporting Systems (L1)		PA 6.1,6.2- EDEMA, HYPEREMIA, CONGESTION-SDL	PRACTICALS MICRO 1.2 GRAM STAINING
20-01-24	Saturday	PANDEMIC MODULE 2.5	IM1.3 RHEUMATIC FEVER	FM1.6 FM1.7 FM1.8 Legal Procedure 3	PA 6.3-SHOCK -INT SESSION	PA 13.2-Anticoagulants in hematology-SDL	Lunch	PH 1.1 Clinical Pharmacology charts - I (SGD1/ Practical)	PH 2.5 pandemic-pharm new drug development
21-01-24	Sunday
22-01-24	Monday	CP	CP	CP	IM3.1 ,3.2 DEFINITION OF PNEUMONIA AND ITS TYPES	MI 1.1 Introduction to Parasitology and lab diagnosis		PH 3.4 ADR REPORTING	PH 3.4 ADR REPORTING
23-01-24	Tuesday	CP	CP	CP	PH 1.8 Drug Interactions (L1)	PA 6.4-THROMBOSIS-SGD	Lunch	MI Antimicrobial resistance-Integration with Pharm	Antimicrobial resistance-Integration with Pharm
24-01-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4+CM 3.3 POLIO(L)	FM1.9 Legal Procedure 4		PA 6.5,6.6-Embolism, infarction-SGD	PA6.5,6.6-embolism,infarction-SGD
25-01-24	Thursday
26-01-24	Friday
27-01-24	Saturday	yoga	OG 4.1 Embryology of fetus, Anatomy and Physiology of placenta and Teratogenesis	FM1.10 FM1.11 Legal Procedure 5	INTERNAL ASSESSMENT - 1 GENERAL MICROBIOLOGY	INTERNAL ASSESSMENT - 1 GENERAL MICROBIOLOGY	LUNCh	pandemic-cm	pandemic -infection control practices hand washing
28-01-24	Sunday
29-01-24	Monday	CP	CP	CP	SU1.2 Describe the factors that affect the metabolic response to injury..	MI 1.1 Epidemiological basis of Infectious Diseases		PH 2.3 Dosage calculations (DOAP1/Practical)	PH 2.3 Dosage calculations (DOAP1/Practical)
30-01-24	Tuesday	CP	CP	CP	PH 1.2 EBM , TDM (L1)	PA 9.1 Principles and mechanism of immunity-SGD	Lunch	MI 1.1 Introduction to Mycology and lab diagnosis	MI 1.1 Normal human microbiata
31-01-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4+CM 3.6,3.7,3.8 JE(L)	CM 8.1,8.3,8.4+CM 3.6,3.7,3.8 JE(L)		PA 9.2 Type 1 and 2 hypersensitivity reaction-SGD	PA 9.2 Type 1 and 2 hypersensitivity reaction-SGD
01-02-24	Thursday	CP	CP	CP	PA 9.2 Type 3 and 4 HSR-SGD	MI 1.1 Sterilisation and disinfection	LUNCH	PH 1.60.1 to 1.60.3 Pharmacogenomics &PharmacoEconomics (L1)	Acute appendicitis - SGD (Practicals)
02-02-24	Friday	CP	CP	CP	PH 1.42 Chemo General principles (L1)	PH 1.42 Chemo sulfa & quinolones (L1)		PA 9.4- Autoimmunity-L	PRACTICALS MICRO 1.2 GRAM STAINING
03-02-24	Saturday	yoga	SU2.1 Describe Pathophysiology of shock, types of shock & principles of resuscitation including fluid replacement and monitoring.	FM2.1 FM2.2 FM2.3 FM2.5 FM2.6 Death & Its causes	PA 9.5-SLE-SGD	pharmacology IA-1 GP		PA 2.4 AETCOM	PA 2.4 AETCOM
04-02-24	Sunday			holiday
05-02-24	Monday	CP	CP	CP	IM autoimmune diseases	MI 1.8 Components of Immune system		PH 2.1 Dosage forms DOAP 1/ Practical	PH 2.1 Dosage forms DOAP 1/ Practical
06-02-24	Tuesday	CP	CP	CP	PH 1.42.BETA LACTAMS (L1)	PA 9.7 OTHER AUTOIMMUNE DISORDERS-SGD	Lunch	MI 1.7 Immunity	MI 1.8 Antigen and antibody
07-02-24	Wednesday	CP	CP	CP	CM 8.1.8.3,8.4 EMERGING DISEASES & RE EMERGING DISEASES (L)	FM2.4 Medical Ethics & Laws	LUNCH	PA 9.3 Transplant rejection -SGD	PA 22.4 - Blood components-SDL
08-02-24	Thursday	CP	CP	CP	Immunodeficiency diseases-L	MI 1.8 Humoral immune response		PH 1.42.BETA LACTAMS (L1)	Reversible cell injury- Kidney (SGD)-Practicals
09-02-24	Friday	CP	CP	CP	PH 1.43 Rational use of antimicrobials including ASP (SGD 1/THEORY)	PH 1.43 Rational use of antimicrobials including ASP (SGD 1/THEORY)		PA 3.1 Amyloidosis-SGD -Practical	PRACTICALS MICRO 1.2 ACID FAST STAINING
10-02-24	Saturday			holiday
11-02-24	Sunday			holiday
12-02-24	Monday	CP	CP	CP	OG 5.1 Preconceptional counselling and screening and management of pre existing medical disorders	MI 1.8 Cell mediated immune response		PH 1.1 Clinical Pharmacology charts - I (SGD1/ Practical)	PH 1.1 Clinical Pharmacology charts - I (SGD1/ Practical)
13-02-24	Tuesday	CP	CP	CP	PH 1.42 Aminoglycosides, Broad spectrum antibiotics (SGD1/Theory)	PA 11.1 Cytogenetic abnormalities in childhood-L	Lunch	INTERNAL ASSESSMENT GENERAL MICROBIOLOGY-II	INTERNAL ASSESSMENT GENERAL MICROBIOLOGY-II
14-02-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4+CM 3.6,3.7,3.8 DENGUE(L)	CM 8.1,8.3,8.4+CM 3.6,3.7,3.8 DENGUE(L)		PA 11.1 Genetics- Lecture	PA 11.1 Genetics-L
15-02-24	Thursday	CP	CP	CP	PA 10.4- Tuberculosis- Int session	MI 1.8,8.15 Antigen antibody reactions I	LUNCH	PH 1.47 Drugs for Kala azar(L1)	Granulation tissue, fatty liver- SGD Practicals
16-02-24	Friday	CP	CP	CP	PH 1.44 ATT drugs (L1)	PH 1.44 ATT drugs, MDR,XDR TB (SGD1) Integration with Chest medicine		PA 11.1 Genetics- Lecture	PRACTICALS MICRO 1.2 ACID FAST STAINING
17-02-24	Saturday	AETCOM- OG	IM heart failure mgt	FM2.7 FM2.8 Post mortem changes 1	IA -1, Chapter 1,2,3	IA -1, Chapter 1,2,3	Lunch	PH 1.47 Antiamoebic drugs (L1)	pandemic-micro
18-02-24	Sunday
19-02-24	Monday	CP	CP	CP	SU2.2 Describe the clinical features of shock and its appropriate treatment.	MI 1.8,8.15 Antigen antibody reactions II		PH 1.45 MDR,XDR TB (L1)	PH 1.47 Antihelminthic drugs (L1)
20-02-24	Tuesday	CP	CP	CP	PH 1.46 Drugs for leprosy- dermatology Integration (L1)	PA 11.1,11.3 -Other genetic disorders- L	Lunch	MI 1.8 Complement	MI 1.10 Hypersensitivity
21-02-24	Wednesday	CP	CP	CP	CM 3.1 AIR POLLUTION (SEMINAR)	FM2.9 Post mortem changes 2		PA 11.1,11.3 Genetics- L	PA 11.1,11.3-Genetis- L
22-02-24	Thursday	CP	CP	CP	PA 7.1 Define neoplasia, benign and malignant neoplasm	MI 1.10 Autoimmunity		PH 1.48 Drugs for STD and UTI (L1)	VIVA 1
23-02-24	Friday	CP	CP	CP	PH 1.47 drugs for malaria(L1)	PH 1.47 drugs for malaria(L1)		PA 7.2- Molecular basis of cancer I-SGD	PRACTICALS MICRO 1.2 ACID FAST STAINING
24-02-24	Saturday	yoga	OG 6.1 Diagnosis of pregnancy, Clinical features and pregnancy tests	FM2.10 Post mortem changes 3	MI 1.10 Immunodeficiency disorders	MI 1.11 Transplant and tumor immunity	LUNCh	pandemic-micro	pandemic -cm
25-02-24	Sunday
26-02-24	Monday	CP	CP	CP	OG 5.2 Immunisation in pregnancy	MI 2.1,2.2 Acute Rheumatic fever		PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)
27-02-24	Tuesday	CP	CP	CP	PH 1.48 Anti Viral, AntiRetroViral (L1)	PA 7.2- Molecular basis of cancer II-SGD	Lunch	MI 2.3,8.15 Infective endocarditis	MI 2.1,2.2,2.4 Blood stream infections
28-02-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4+CM 3.6,3.7,3.8 MALARIA & FILARIA (L)	CM 8.1,8.3,8.4+CM 3.6,3.7,3.8 MALARIA & FILARIA (L)		PA 9.6 -HIV-Integrated session	PA 9.6 -HIV-Integrated session
29-02-24	Thursday	CP	CP	CP	PA 7.3- Carcinogens-L	Fever of unknown origin	LUNCH	PH 1.48 Anti Viral, AntiRetroViral (L1)	CVC Liver, Lung- SGD -Practical
01-03-24	Friday	CP	CP	CP	PH 1.49 Anticancer drugs (L1)	PH 1.49 Anticancer drugs (L1)		PA 10.1-Malaria- Integrated session	Microbiology
02-03-24	Saturday	yoga	SU2.3 Communicate and counsel patients and families about the treatment and prognosis of shock demonstrating empathy and care	FM2.11 FM2.12 FM2.13 FM2.14 Medicolegal autopsy 1	PA 10.3 Leprosy-L	Pharmacology IA- 2 chemo-1		PA 2.4 AETCOM	PA 2.4 AETCOM
03-03-24	Sunday			holiday
04-03-24	Monday	CP	CP	CP	anemia	MI 2.5,8.16 Anemia agent- Malaria		PH 2.3 IV Drip setting DOAP1/Practical	PH 2.3 IV Drip setting DOAP1/Practical
05-03-24	Tuesday	CP	CP	CP	PH 1.48 Anti fungal drugs (L1)	PA10.4 Syphilis-L	Lunch	MI 2.5,8.16 Anemia agent- Malaria	MI 3.1 Anemia agent- Hookworm
06-03-24	Wednesday	CP	CP	CP	INTERNAL ASSESSMENT -I	FM 2.15 Medicolegal autopsy 2	LUNCH	PA 7.2- Angiogenesis, invasion, metastasis, evasion of host defenses-SGD	PA 7.2- Angiogenesis, invasion, metastasis, evasion of host defenses-SGD
07-03-24	Thursday	CP	CP	CP	PA 9.3- Transplant rejection-SDL	MI 2.6,8.15 Anemia agent- Leishmania		PH 1.50 Immunomodulators (L1)	Organization of thrombus, atheroma- SGD(Practical)
08-03-24	Friday	CP	CP	CP	PH 1.14 Intro to ANS (L1)	PH 1.14 Cholinergic Transmission & Drugs (L1)		PA 7.4 Paraneoplastic syndrome- SGD	Microbiology
09-03-24	Saturday			holiday
10-03-24	Sunday			holiday
11-03-24	Monday	CP	CP	CP	OG 7.1 Maternal changes in pregnancy	MI 2.6,8.15 Trypanosoniasis		PH 3.1 Prescription writing (Skill station SGD1/Practical)	PH 3.1 Prescription writing (Skill station SGD1/Practical)
12-03-24	Tuesday	CP	CP	CP	PH 1.14 AntiCholinergic Drugs (L1)	PA 12.2 PEM -L	Lunch	MI 3.4,8.15 Leptospira	MI 8.1 Brucella,Borrelia
13-03-24	Wednesday	CP	CP	CP	CM 3.1WATER POLLUTION (SEMINAR)	CM 3.1WATER POLLUTION (SEMINAR)		PA 12.1 - Tobacco and alcohol-SGD	PA 12.1 - Tobacco and alcohol-SGD
14-03-24	Thursday	CP	CP	CP	PA 12.3 Obesity- Int session	MI 1.1,8.15 Viral hemorrhagic fever	LUNCH	PH 1.14 AntiCholinergic Drugs (L1)	Capillary and cavernous hemangioma- SGD Practical
15-03-24	Friday	CP	CP	CP	PH 1.13 Adrenergic Drugs (L1)	PH 1.13 Adrenergic Drugs (L1)		Neonatal RDS, Necrotizing enterocolitis-SGD	Microbiology
16-03-24	Saturday	PANDEMIC MODULE 2.5	IM 9.1 DEFIN AND CLASSIFY ANEMIA	FM2.16 FM2.17 Medicolegal autopsy 3	IA 2 Hemodynamic disorders, Genetics	IA2- Hemodynamic disorders, Genetics	Lunch	PH 1.13 Adrenergic Drugs (L1)	pandemic - cm
17-03-24	Sunday			holiday
18-03-24	Monday	CP	CP	CP	SU3.1 Describe the Indications and appropriate use of blood and blood products and complications of blood transfusion.	MI 1.1,8.15 Rickettsial infections		PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)
19-03-24	Tuesday	CP	CP	CP	PH 1.13 Anti Adrenergic Drugs (L1)	PA 11.3 Perinatal infections, fetal hydrops-SGD	Lunch	INTERNAL ASSESSMENT - IMMUNOLOGY	INTERNAL ASSESSMENT - IMMUNOLOGY
20-03-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4 ARI(L)	FM2.18 Medicolegal autopsy 4		PA 11.3 Cystic fibrosis , SIDS -SGD	VIVA 2
21-03-24	Rickettsial Infections	CP	CP	CP	PA 11.2 Tumors of infancy-SGD	MI 1.1,8.15 Systemic mycoses I-Candida		PH 1.13 Anti Adrenergic Drugs (L1)	LIPOMA, ACTINOMYCOSIS -PRACTICAL-SGD
22-03-24	Friday	CP	CP	CP	PH 1.13 Anti Adrenergic Drugs (L1)	PH 1.15 Sketal Muscle relaxing agents (L1)		General principles of Microbial infections	Microbiology
23-03-24	Saturday	yoga	OG 8.1 Antenatal Care	FM2.19 Anaesthetic & Operative death	INTEGRATED HIV/AIDS	INTEGRATED HIV/AIDS	LUNCh	pandemic-cm	pandemic-cm
24-03-24	Sunday			holiday
25-03-24	Monday	CP	CP	CP	OG 9.1 Etiology, Diagnosis and Management of Abortion	MI 1.1,8.15 Systemic mycoses - II		PH 4.2 CAL (SGD1/ Practical)	PH 4.2 CAL (SGD1/ Practical)
26-03-24	Tuesday	CP	CP	CP	PH 1.17 Local Anaesthetics (L1)	PA 10.4 Viral infections- seminar/SDL	Lunch	MI 3.1 Diarrhoea and gastroenteritis-Introduction	MI 3.1 Escherichia coli
27-03-24	Wednesday	CP	CP	CP	CM 8.1,8.3,8.4 HEPATITIS (L)	CM 8.1,8.3,8.4 HEPATITIS (L)		PA 10.4 Bacterial ,fungal and parasitic infestations-SDL/Seminar	PA 10.4 Bacterial ,fungal and parasitic infestations-SDL/Seminar
28-03-24	Thursday	CP	CP	CP	Air pollution -PA 12.1, SDL/Seminar	MI 3.1 Vibrio Cholera	LUNCH	PH 1.26 RAAS (SDL)	Squamous cell carcinoma- SGD-Practicals
29-03-24	Friday			holiday
30-03-24	Saturday	AETCOM MODULE 2.1 medicine	SU3.3 Counsel patients and family/ friends for blood transfusion and blood donation.	FM2.20 FM2.21 Asphyxia 1	MI 3.2 NTS and Shigella	PH 1.26 RAAS (SDL)		PH5.1 AETCOM Convince a patient to go to authorized medical practitioner	PH 5.2AETCOM Communicating the diagnosis and Drug Therapy For Tuberculosis
31-03-24	Sunday			holiday
01-04-24	Monday	CP	CP	CP	IM dyslipidemia	MI 3.5 Food poisoning		PH 4.2 CAL (SGD1/ Practical)	PH 4.2 CAL (SGD1/ Practical)
02-04-24	Tuesday	CP	CP	CP	PH 1.28 Angina,MI,PVD INTEGRATION (L1)	PA 27.1- ATHEROSCLEROSIS - L	Lunch	MI 3.5 Clostridium botulinum and Clostridium difficile	MI 3.5 Clostridium perfringens
03-04-24	Wednesday	CP	CP	CP	CM 3.7,3.8 MEDICAL ENTOMOLOGY-PART 1(L)	CM 3.7,3.8 MEDICAL ENTOMOLOGY-PART 1(L)		PA 27.2 ANEURYSM - L	PA 27.2 ANEURYSM - L
04-04-24	Thursday	CP	CP	CP	Hypertension , hypertensive heart disease SDL	MI 3.5 Staphylococcus aureus	LUNCH	PH 1.28 Angina,MI,PVD (L1)	PA 19.5 GROSS & MICROSCOPIC FEATURES - HODGKIN LYMPHOMA -DOAP
05-04-24	Friday	CP	CP	CP	PH 1.27 Antihypertensives- Integration with GM- (L1)	PH 1.27 Antihypertensives- (SGD1Theory)		vasculitis , blood vessel disorders (SGD)	Microbiology
06-04-24	Saturday	yoga	SU5.1 Describe normal wound healing and factors affecting healing.	FM2.22 FM2.23 Asphyxia 2	PA27.3 congenital heart disease (SGD)	Pharmacology IA-3 CHEMO-2		MI AETCOM	MI AETCOM
07-04-24	Sunday			holiday
08-04-24	Monday	CP	CP	CP	OG 10.2 Appropriate use of Blood and Blood Products in pregnancy	MI 3.1,3.6 Diarrhoea causing Agents - Campylobacter,H.pylori,Bacillus cereus		PH 3.1 Prescription writing (Skill station SGD1/Practical)	PH 3.1 Prescription writing (Skill station SGD1/Practical)
09-04-24	Tuesday			holiday
10-04-24	Wednesday	CP	CP	CP	CM 3.1 NOISE POLLUTION &EFFECTS OF RADIATION (SEMINAR)	FM2.24 FM2.25 Thermal Injuries	LUNCH	PA 27.4 valvular heart disease , RHD -L	Cardiovascular diseases in syphilis -SDL-PA 27.10
11-04-24	Thursday			holiday
12-04-24	Friday	CP	CP	CP	PH 1.27 Antihypertensives- (SGD1Theory)	PH 1.27 Antihypertensives- (SGD1Theory)		PA 27.6-INFECTIVE ENDOCARDITIS-SGD	Microbiology
13-04-24	Saturday			holiday
14-04-24	Sunday			holiday
15-04-24	Monday	CP	CP	CP	PA5.1 Define and describe the process of repair and regeneration including wound healing and its types	MI 3.1 Intestinal Amoebiasis and Giardiasis		PH 3.2 CHEMO- PA SGD1/ Practical	PH 3.2 CHEMO- PA SGD1/ Practical
16-04-24	Tuesday	CP	CP	CP	PH 1.24 Diuretics & Antidiuretics (SDL)	PA 27.7-PERICARDITIS, PERICARDIAL EFFUSION-L	Lunch	INTERNAL ASSESSMENT - IV CVS AND BSS	INTERNAL ASSESSMENT - IV CVS AND BSS
17-04-24	Wednesday	CP	CP	CP	CM 14.1,14.3 BIOMEDICAL WASTE MANAGEMENT (SEMINAR)	CM 14.1,14.3 BIOMEDICAL WASTE MANAGEMENT (SEMINAR)		PA27.5 IHD, Acute coronary syndromes-Integrated session	PA 27.5 IHD, Acute coronary syndromes- Integrated session
18-04-24	Thursday	CP	CP	CP	PA27.9-Cardiomyopathy, cardiac tumors-L	MI 3.1 Coccidian parasites	LUNCH	PH 1.24 Diuretics & Antidiuretics (SDL)	Bronchiectasis- SGD(Practical)
19-04-24	Friday	CP	CP	CP	PH 1.29 Heart Failure (L1)	PH 1.30 Antiarrhythmias drugs (L1)		Election -holiday	Microbiology
20-04-24	Saturday	AETCOM - sur	IM5.1 BILIRUBIN METABOLISM	Starvation FM2.26	Physical examination of urine-Lecture	Physical examination of urine-Lecture	Lunch	PH 1.30 Antiarrhythmias drugs (SDL)	PH 5.2 AETCOM Drug complaince for hypertension
21-04-24	Sunday			holiday
22-04-24	Monday	CP	CP	CP	protozoal infections	Clostridium difficile,perfringens, Botulism		PH 3.2 CHEMO- PA SGD1/ Practical	PH 3.2 CHEMO- PA SGD1/ Practical
23-04-24	Tuesday	CP	CP	CP	PH 1.25 Coagulants & Anticoagulants(L1)	Chemical examination of urine-I (SGD)	Lunch	Lab diagnosis of Food Poisoning	camphylobacter, V.parahemolyticus,B.cereus, H.pylori
24-04-24	Wednesday	CP	CP	CP	CM 3.5 HOUSING STANDARDS (SEMINAR)	FM2.27 Infanticide 1		IA -3	IA-3
25-04-24	Thursday	CP	CP	CP	ARDS,ALI, PULMONARY EDEMA-SGD	Viral Gastroenteritis		PH 1.25 Coagulants & Anticoagulants(L1)	Fibroadenoma, ascitic fluid positive for malignancy-SGD practical
26-04-24	Friday	CP	CP	CP	PH 1.25 Fibrinolytics & Antifibrinolytics (L1)	PH 1.25 Fibrinolytics & Antifibrinolytics (L1)		Chemical examination of urine-II (SGD)	Microbiology
27-04-24	Saturday	yoga	OG 12.2 Anemia in Pregnancy	FM2.28 Infanticide 2	microbiology	intestinal Amoebiasis,giardiasis,coccidian parasites	LUNCh	pandemic- micro	Pandemic CM
28-04-24	Sunday			holiday
29-04-24	Monday	CP	CP	CP	MI1.4 Classify and describe the different methods of sterilization and disinfection. Discuss the application of the different methods in the laboratory, in clinical and surgical practice	Intesinal Cestode infections D.latum,H.nana,taenia		Pharmacology	Pharmacology
30-04-24	Tuesday	CP	CP	CP	PH 1.25 Antiplatelets (L1)	PA26.5 Pneumoconiosis- lecture	Lunch	Intestinal Trematode infections f.buski,s.mansoni,s.japonicum	Intestinal Nematode infections Trichuris,Enterobius,Ascaris,Strongyloides,Hookworm
01-05-24	Wednesday
02-05-24	Thursday	CP	CP	CP	Practical assessment revision (SGD)	Lab Diagnosis of Diarrhoea	LUNCH	PH 3.4.1 - 3.4.8 To Recognise and report ADR(SGD/practical)	PAP ESTROGENIC, PROGESTEROGENIC PHASE- PRACTICAL
03-05-24	Friday	CP	CP	CP	PH 1.13.1 - 1.15.21	ANS & PNS(SGD/Theory)		COPD-EMPHYSEMA, CHRONIC BRONCHITIS-Lecture PA 26.3	Microbiology
04-05-24	Saturday	yoga	SU6.1 Define and describe the aetiology and pathogenesis of surgical Infections	FM2.29 Legal Procedure	INFECTIOUS DISEASES TRANSMITTED BY BLOOD TRANSFUSION-SDL	PH 3.5.1 - 3.5.5 P Drug (SGD/Practical)		PH AETCOM ADR reported by patient	PH convince the parent for iv cannulation to child
05-05-24	Sunday			holiday
06-05-24	Monday	CP	CP	CP	ulcer mgt	Infective Syndromes of Hepatobiliary system, Yellow Fever		PH 4.1 Intravenous route of administration (DOAP)
07-05-24	Tuesday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
08-05-24	Wednesday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
09-05-24	Thursday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
10-05-24	Friday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
11-05-24	Saturday
12-05-24	Sunday
13-05-24	Monday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
14-05-24	Tuesday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
15-05-24	Wednesday	CP	CP	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1	PCT -1
16-05-24	Thursday	CP	CP	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
17-05-24	Friday	CP	CP	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
18-05-24	Saturday	PANDEMIC MODULE 2.5	coagulation disorders	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
19-05-24	Sunday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
20-05-24	Monday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
21-05-24	Tuesday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
22-05-24	Wednesday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
23-05-24	Thursday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
24-05-24	Friday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
25-05-24	Saturday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
26-05-24	Sunday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
27-05-24	Monday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
28-05-24	Tuesday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
29-05-24	Wednesday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
30-05-24	Thursday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
31-05-24	Friday	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION	VACATION
01-06-24	Saturday	yoga	PA8.1 Describe the diagnostic role of cytology and its application in clinical care	FM2.33 FM2.34 Mass Disaster	Bronchial asthma and bronchiectasis- PA26.3	PH 4.2.1-4.2.5 DPL		PA 2.8 AETCOM	PA 2.8 AETCOM
02-06-24	Sunday		holiday
03-06-24	Monday	CP	CP	CP	IM5.4 EPIDEMIOLOGY OF VIRAL HEPATITIS	lab diagnosis of hepatitis		PH 2.3.1-2.3.8 IV DRIP SETTING- SGD2/ Practical
04-06-24	Tuesday	CP	CP	CP	PH 1.35.1-1.35.8 Drugs affecting blood formation(SGD1/Theory)	Restrictive lung disease and pulmonary vascular disorders	Lunch	staphylococcus infections	trematode infections of hepatic system
05-06-24	Wednesday	CP	CP	CP	CM 3.4 SOLID WASTE MANAGEMENT (SEMINAR)	FM2.35 Medicolegal Autopsy	LUNCH	PA 26.1, PA26.2 PNEUMONIA , LUNG ABSCESS-sgd	PA 26.1, PA26.2 PNEUMONIA , LUNG ABSCESS-SGD
06-06-24	Thursday	CP	CP	CP	PA 24.1, ORAL & SALIVARY GLAND TUMORS-LECTURE	Streptococcal infection		PH 1.33.1-1.33.7 Drugs for cough (SGD1 Theory)	pathology
07-06-24	Friday	CP	CP	CP	PH 1.32 Bronchial Asthma & COPD-(L1)	PH 1.32 Bronchial Asthma & COPD-Integn.with Chest Medicine (L1)		DISEASES OF ESOPHAGUS-LECTURE	Microbiology
08-06-24	Saturday		holiday
09-06-24	Sunday		holiday
10-06-24	Monday	PTA	PTA	PTA	PTA	gas gangrene	PTA	PH 1.3.1-1.3.5 Special drug delivery system	PTA
11-06-24	Tuesday	CP	CP	CP	PH 1.34Antiemetics & Prokinetics (L1)	PA24.2,24.3- PEPTIC ULCER DISEASE, Lecture	Lunch	cutaneous viral infections	anthrax , non veneral trepanomatoses
12-06-24	Wednesday	CP	CP	CP	CM 3.7,3.8 INTEGRATED VECTOR MANAGEMENT(L)	CM 3.7,3.8 INTEGRATED VECTOR MANAGEMENT(L)		PA 24.4- CARCINOMA OF STOMACH-LECTURE	PA 24.4- CARCINOMA OF STOMACH-LECTURE
13-06-24	Thursday	CP	CP	CP	PA24.5, ULCERATIVE LESIONS OF SMALL AND LARGE INTESTINE, TB, TYPHOID, AMEBIASIS - SGD	pandemic module	LUNCH	PH 1.34 Drugs for constipation, Diarrhoea,( SGD1/Theory)	PATH PRACTICALS Melanoma
14-06-24	Friday	CP	CP	CP	PH 1.34 APD & GERD integration with Microbiology (SGD1/Theory)	PH 1.34 APD & GERD integration with Microbiology (SGD1/Theory)		CHARM - OD	Microbiology
15-06-24	Saturday	PTA	PTA	PTA FM3.2 Identification	CHARM	CHARM	Lunch	PTM	pandemic-cm
16-06-24	Sunday		holiday
17-06-24	Monday
18-06-24	Tuesday	CP	CP	CP	PH 1.34 APD & GERD integration with Microbiology (SGD1/Theory)	POLYPS OF INTESTINE - LECTURE	Lunch	ACTINOMYCOSIS , NOCARDIOSIS	Pox Virus, V-Z,parvo virus
19-06-24	Wednesday	CP	CP	CP		FM3.3 FM3.4 FM3.5 FM3.6 Mechanical injuries 1		PA 24.6 INFLAMMATORY BOWEL DIASEASE - SGD	PA 24.6 INFLAMMATORY BOWEL DIASEASE - SGD
20-06-24	Thursday	CHEMFEST/SPORTS	CHEMFEST/SPORTS	CHEMFEST/SPORTS	CHEMFEST/SPORTS	CHEMFEST/SPORTS	CHEMFEST/SPORTS	CHEMFEST/SPORTS	CHEMFEST/SPORTS
21-06-24	Friday	CP	CP	CP	CHEMFEST/SPORTS	CHEMFEST/SPORTS		CHEMFEST/SPORTS	CHEMFEST/SPORTS
22-06-24	Saturday	yoga	OG 12.3 Diabetes in pregnancy	Mechanical injuries 2 FM3.7	CHEMFEST/SPORTS	CHEMFEST/SPORTS	LUNCh	CHEMFEST/SPORTS	CHEMFEST/SPORTS
23-06-24	Sunday		holiday
24-06-24	Monday	CP	CP	CP	meningitis mgt	CHEMFEST/SPORTS		CHEMFEST/SPORTS	CHEMFEST/SPORTS
25-06-24	Tuesday	CP	CP	CP	PH 1.34.24-1.34.26 IBD	MALABSORPTION SYNDROME -LECTURE	Lunch	LEPROSY	MEASLES,RUBELLA,COXSACKIE
26-06-24	Wednesday	CP	CP	CP	INTERNAL ASSESSMENT -II	INTERNAL ASSESSMENT -II		PA 25.3 VIRAL HEPATITIS - INTERGRATED - class cancelled ( mentor mentee meeting)	PA 25.3 VIRAL HEPATITIS - INTERGRATED, class cancelled - mentor mentee meeting
01-07-24	Monday	CP	CP	CP	stroke	dracunculiasis,trichenellosis,cutaneous larva migrans		PH 2.2ORS (SGD1/ Practical)	PH 2.2ORS (SGD1/ Practical)
27-06-24	Thursday	CP	CP	CP	PA 25.1 JAUNDICE, AUTOIMMUNE CHOLANGIOPATHIES, STRUCTURAL ANOMALIES OF BILIARY TREE - SGD	cutaneous leishmaniasis,filariasis	LUNCH	PH 1.16 5-HT antagonist - Drug therapy of migraine(L1)	PATH PRACTICALS GASTRIC ULCER
28-06-24	Friday	CP	CP	CP	Tamil mandram	Tamil mandram		Tamil mandram	Tamil mandram
29-06-24	Saturday	Yoga	OG 12.1 Hypertensive Disorders in pregnancy	Mechanical injuries 3 FM3.8	Tamil mandram	Tamil mandram		Tamil mandram	Tamil mandram
30-06-24	Sunday			holiday
02-07-24	Tuesday	CP	CP	CP	PH 1.19 Sedatives-hypnotics/Anxiolytics (L1)	Carcinoma colon-L PA24.6	Lunch	Superficial & S.C Mycosis - P. marneffi, Candidiasis	Infective syndromes of Respiratory tract Bacterial Pharyngitis - Streptococcus
03-07-24	Wednesday	CP	CP	CP	CM8.1,8.3,8.4 CHALLENGES FACED IN PREVENTION OF OF EMERGING &RE-EMERGING INFECTION	CM8.1,8.3,8.4 CHALLENGES FACED IN PREVENTION OF OF EMERGING &RE-EMERGING INFECTION		Internal assessment 4	Internal assessment 4
04-07-24	Thursday	CP	CP	CP	PA 25.2,25.5 - hepatic failure, portal hypertension -L	Bacterial Pharyngitis - Diphtheria	LUNCH	PH 1.19 Antipsychotic drugs (L1)	PATH PRACTICAL- CIRRHOSIS, METS NODE, HCC CHART
05-07-24	Friday	CP	CP	CP	PH 1.18 General Anaesthetics Integration with Anaesthesia (L1)	PH 1.18 General Anaesthetics Integration with Anaesthesia (L1)		PA 25.4 ALD, NAFLD, CIRRHOSIS (SGD)	bacterial culture - e.coli, klebsiella, staphylococcus aureus, proteus (SGD)
06-07-24	Saturday	yoga	SU 6.2 Enumerate Prophylactic and therapeutic antibiotics Plan appropriate management	FM3.9 Mechanical injuries 4	inherited liver diseases-L	Pharmacology IA-6 RS ,GIT		PA 2.8 AETCOM	PA 2.8 AETCOM
07-07-24	Sunday			holiday
08-07-24	Monday	CP	CP	CP	OG 13.1 physiology &Mechanism of Labour	Pneumococcus, H.Influenza		PH 3.5 P-drug (SGD1/ Practical)	PH 3.5 P-drug (SGD1/ Practical)
09-07-24	Tuesday	CP	CP	CP	PH 1.19 Antipsychotic drugs (L1)	Tumors of liver -L	Lunch	Tuberculosis INTEGRATED LECTURE	Tuberculosis INTEGRATED LECTURE
10-07-24	Wednesday	CP	CP	CP	CM8.1,8.3,8.4,8.5 COVID 19 SEMINAR	FM3.10 Mechanical injuries 5	LUNCH	Diseases of gall bladder- SGD	PATH PRACTICAL - MELANOMA, CARCINOMA COLON, GASTRIC ULCER
11-07-24	Thursday	CP	CP	CP	PA 32.6-Diseases of pancreas - lecture	Non Tuberculous Mycobacteria		PH 1.19 Parkinsonism – Drugs for Neurodegenerative disorders (L1)	PATH PRACTICAL - CPN,RCC
12-07-24	Friday	CP	CP	CP	PH 1.19 Antidepressants Antimaniac drugs (L1)	PH 1.19 Antidepressants Antimaniac drugs (L1)		PA 28.5 glomerulonephritis	bacterial culture - e.coli, klebsiella, staphylococcus aureus, proteus (SGD)
13-07-24	Saturday			holiday
14-07-24	Sunday			holiday
15-07-24	Monday	CP	CP	CP	SU 14.1 Describe Aseptic techniques, sterilization and disinfection.	Atypical Pneumonia		Pharmacology	Pharmacology
16-07-24	Tuesday	CP	CP	CP	PH 1.19 Anti Epileptic Drugs (SGD1/Theory)	nephrotic syndrome -MCD,MN,FSGS,MPGN-L	Lunch	PERTUSSIS	non fermenting -pseudomona, acinetobacter, burkholderia
17-07-24	Wednesday
18-07-24	Thursday	CP	CP	CP	PA28.6,28.7 IgA nephropathy, alports syndrome -sgd	myxovirus infections - influenza and parainfluenza	LUNCH	PH 1.19 Anti Epileptic Drugs (SGD1/Theory)	PATH PRACTICAL - WILMS TUMOR, TERATOMA
19-07-24	Friday	CP	CP	CP	PH 1.19 Opioid Analgesics & Antagonists (L1)	PH 1.19 Opioid Analgesics & Antagonists (L1)		PA28.8,28.9-ATN, TUBULAR INTERSTITIAL DISEASE - SGD	immunoserology- ASO , CRP, RF
20-07-24	Saturday	PANDEMIC MODULE 2.5	IM12.1 EPIDEMIOLOGY AND PATHOGENESIS OF THYROID DYSFUNCTION	FM3.11 FM3.12 Regional Injuries	IA5	IA5	Lunch	PH 1.23 Drug Deaddiction -SGD1	PH 2.5 Discuss ethical aspects of clincal trials in pandemic
21-07-24	Sunday			holiday
22-07-24	Monday	CP	CP	CP	SU 14.2 Describe Surgical approaches, incisions and the use of appropriate instruments in Surgery in general.	Corona virus infections including COVID-19		PH 3.3 DPL- SGD1/ Practical	PH 3.3 DPL- SGD1/ Practical
23-07-24	Tuesday	CP	CP	CP	PH 1.22 Drugs of Abuse INTEGRATION with PSYCHIATRY (SGD1/Theory)	PA28.10- CPN ,REFLUX NEPHROPATHY -SGD	Lunch	Miscellaneous viral infections	Parasitic infections
24-07-24	Wednesday	CP	CP	CP	CM 19.1,19.2,19.3 VACCINES IN DISEASE CONTROL	FM3.13 Sexual Offences 1		PA 28.11 vascular diseases of kidney-L	viva 3
25-07-24	Thursday	CP	CP	CP	PA 28.12 cystic diseases of kidney-SGD	Fungal infections-Zygomycosis,Aspergillosis		PH 1.20 Alcohol (SGD1/Theory)	PATH PRACTICAL - LEIOMYOMA, PAP HSIL
26-07-24	Friday	CP	CP	CP	PH 1.21 Methanol and Ethanol poisoning(SGD1/Theory)	PH 1.21 Methanol and Ethanol poisoning(SGD1/Theory)		PA 28.13 renal stone (SGL)	immunoserology- ASO , CRP, RF
27-07-24	Saturday	yoga		FM3.14 Sexual Offences 2	INTERNAL ASSESSMENT-VI	INTERNAL ASSESSMENT-VI	LUNCh	pandemic-micro	pandemic -cm
28-07-24	Sunday			holiday
29-07-24	Monday	CP	CP	CP	IM10.2 ACUTE RENAL FAILURE	Infective syndromes of central nervous system		PH 3.5 P-drug (SGD1/ Practical)	PH 3.5 P-drug (SGD1/ Practical)
30-07-24	Tuesday	CP	CP	CP	PH 1.37 Pituitary hormones (L1)	PA 28.14 renal tumors -SGD	Lunch	Acute bacterial meningitis: N.meningitidis, S. pneumoniae, S.agalactiae, H.influenzae, Listeria	Chronic bacterial meningitis: Tubercular meningitis, spirochaetal meningitis, lyme disease and others
31-07-24	Wednesday	CP	CP	CP	CM 19.5 ROUTINE VACCINATION DURING PANDEMIC(L)	CM 19.5 ROUTINE VACCINATION DURING PANDEMIC(L)		PA 28.16 UROTHELIAL TUMORS- INTERGRATED SESSION	PA 28.16 UROTHELIAL TUMORS- INTERGRATED SESSION
01-08-24	Thursday	CP	CP	CP	PA 29.1 testicular tumors-sgd	Tetanus	LUNCH	PH 1.36 Osteoporosis (SGD1/Theory)	PATH PRACTICALS - endometrium proliferative and secretory phase- sgd
02-08-24	Friday	CP	CP	CP	PH 1.38 Corticosteroids (L1)	PH 1.38 Corticosteroids (L1)		PA 29.2 carcinoma penis- SGD	Microbiology
03-08-24	Saturday	yoga	SU 15.1 Describe classification of hospital waste and appropriate methods of disposal.	FM3.15 FM3.16 Sexual Offences 3	PA carcinoma prostate, bph, prostatitis- lecture	Pharmacology IA-7 Autacoids		MI AETCOM	MI AETCOM
04-08-24	Sunday			holiday
05-08-24	Monday	CP	CP	CP	IM10.5 CHRONIC RENAL FAILURE	Viral meningitis and viral myelitis: Poliomyelitis, coxsackievirus		PH 3.4 ADR REPORTING	PH 3.4 ADR REPORTING
06-08-24	Tuesday	CP	CP	CP	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	Local holiday	Lunch	Viral Encephalitis and Encephalopathy-1 Rabies, HSV encephalitis	Viral Encephalitis and Encephalopathy-2 Arboviral encephalitis (J.E & West Nile), Nipah and Hendra, slow virus and prion disease,
07-08-24	Wednesday	CP	CP	CP	CM 6.4 SAMPLING METHODS	FM3.17 Sexual Offences 4	LUNCH	PA 25.3,PA25.6 -viral hepatitis integrated session	PA 30.1,30.6- carcinoma cervix ,cervicitis- sgd
08-08-24	Thursday	CP	CP	CP	PA 30.7,30.8,30.3- endometriosis, adenomyosis, myometrial tumors- sgd	Parasitic infections: Neurocysticercosis, free-living Amoeba infection		PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	path practical tb intestine, tb node cytology - sgd
09-08-24	Friday	CP	CP	CP	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)		PA 30.4 ovarian tumors (lecture)	Microbiology
10-08-24	Saturday			holiday
11-08-24	Sunday			holiday
12-08-24	Monday	CP	CP	CP	OG 16.1 Post partum haemorrhage diagnosis and management	Parasitic infections: Toxoplasmosis		PH 3.1 PW- SGD1/ Practical	PH 3.1 PW- SGD1/ Practical
13-08-24	Tuesday	CP	CP	CP	PH 1.37 Pituitary hormones (L1)	PA 30.5 gestational trophoblastic tumors(SGD)	Lunch	Fungal infections: Cryptococcal meningitis	UTI: Enterobacteriaceae, Enterococcus and others
14-08-24	Wednesday	CP	CP	CP	CM 6.3 TEST OF SIGNIFICANCE	CM 6.3 TEST OF SIGNIFICANCE		Internal assessment 6	PA30.2,30.9 endometrial tumors- integrated session
15-08-24	Thursday		holiday
16-08-24	Friday	CP	CP	CP	PH 1.36 Drugs used in DM (L1)	PH 1.36 Drugs used in DM (L1)		PA 31.1,31.4 benign lesion breast, gynecomastia- SGD	Microbiology
17-08-24	Saturday	AETCOM - sur	BPH management	FM3.18 Virginity	peripheral smear examination, interpretation -SGD	peripheral smear examination, interpretation -SGD	Lunch	PH 1.38 Corticosteroids (L1)	pandemic-cm
18-08-24	Sunday		holiday
19-08-24	Monday	CP	CP	CP	SU 12.1 Enumerate the causes and consequences of malnutrition in the surgical patient	UTI -Viral (BK virus), parasitic (Schistosoma haematobium) and fungal infections		PH 3.2 PA SGD1/ Practical	PH 3.2 PA SGD1/ Practical
20-08-24	Tuesday	CP	CP	CP	PH 1.36 Osteoporosis (SGD1/Theory)	PA 31.2 Carcinoma breast lecture	Lunch	Ulcerative Genital Infections Syphilis, LGV	Granuloma inguinale,Soft Chancre,HSV2
21-08-24	Wednesday	CP	CP	CP	ICDS	FM3.19 Pregnancy and Delivery 1		PA 32.1,32.2,32.3- goiter, graves disease, thyroiditis- SDL	Fibroadenoma, carcinoma breast, (SGD- practical)
22-08-24	Thursday	CP	CP	CP	PATH thyroid neoplasms -lecture	Gonorrhoea,NGU		PH 1.37 Androgens & Anti androgens (L1)	colloid goiter , papillary carcinoma, hashimoto thyroiditis-PATH practical,SGD
23-08-24	Friday	CP	CP	CP	PH 1.37 Estrogens & Progestins (SGD1/Theory)	PH 1.37 Estrogens & Progestins (SGD1/Theory)		PA 32.4 diabetes mellitus SGD	Fungal culture-SGD
24-08-24	Saturday	yoga	OG 14.1 Fetal skull and maternal pelvis	FM3.20 Pregnancy and Delivery 2	INTERNAL ASSESSMENT	INTERNAL ASSESSMENT	LUNCh	pandemic - micro	sports
25-08-24	Sunday		holiday
26-08-24	Monday		holiday
27-08-24	Tuesday	CP	CP	CP	PH 1.41 Uterine stimulants & tocolytics (SGD1/Theory)	PA 32.9 MEN, adrenal neoplasms, pheochromocytoma - lecture	Lunch	Trichomoniasis,Bacterial vaginosis and Vaginal candidiasis	Ocular,Ear, Nose infections
28-08-24	Wednesday	CP	CP	CP	INTERNAL ASSESSMENT III	INTERNAL ASSESSMENT III		PA32.5,32.8-cushings syndrome, adrenal insufficiency SDL-	VIVA 4 and 5
29-08-24	Thursday	CP	CP	CP	Benign lesions of skin -SGD pathology	Congenital infections TORCH complex, Zika virus	LUNCH	PH 1.40 Drugs for Infertility(L1)	osteosarcoma, osteoclastoma, osteochondroma -SGD pathology practical
30-08-24	Friday	CP	CP	CP	PH 1.36 Thyroid and Antithyroid drugs (L1)	PH 1.36 Thyroid and Antithyroid drugs (L1)		PA 34.1,34.2,34.3Malignant skin tumors- SGD	Fungal culture
31-08-24	Saturday	AETCOM - OG	OG 19.1 Physiology of Peurperium	FM3.21 Pregnancy and Delivery 3	microbiology	PH 1.40 Drugs for erectile dysfunction (L1)		PH 2.6 AETCOM- Bioethics	PH 2.6 AETCOM- Bioethics
01-09-24	Sunday		holiday
02-09-24	Monday	CP	CP	PCT 2	PCT 2	PCT 2	PCT 2	PCT 2	PCT 2
03-09-24	Tuesday	CP	CP	PCT 2	PA 33.1,33.4- Metabolic diseases of bone-SGD	PCT 2	PCT 2	PCT 2	PCT 2
04-09-24	Wednesday	CP	CP	PCT 2	PCT 2	PCT 2	PCT 2	PA 33.2- BONE TUMOR-Integrated session	VIVA 6
05-09-24	Thursday	CP	CP	PCT 2	PA 33.5 Arthritis-SGD	PCT 2	PCT 2	PCT 2	Hodgkin lymphoma, Secondary carcinomatous deposits, TB nodes-SGD Practical
06-09-24	Friday	CP	CP	PCT 2	PCT 2	PCT 2	PCT 2	SA 33.3 Soft tissue tumors-SGD	PCT 2
07-09-24	Saturday	yoga	surgery theory	PCT 2	PCT 2	PCT 2	PCT 2	PCT 2	PCT 2
08-09-24	Sunday		holiday
09-09-24	Monday	CP	CP	CP	OG 21.1 Methods of Contraception	Oncogenic virus HPV,Kaposi,HTLV,EBV,HEP B,C		PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)
10-09-24	Tuesday	CP	CP	CP	PH 1.39 Drugs used for Contraception (SGD1/Theory)	IA7	Lunch	Zoonotic infection-Plague,Tularemia, Bite wound infection	Opportunistic and transplant infection
11-09-24	Wednesday	CP	CP	CP	CM 8.5 IMPORTANT PUBLIC HEALTH EVENTS	Impotence and Sterility 2 FM3.23	LUNCH	PA 13.1,13.3,14.1,14.2- Iron def anemia-L	PA 15.1,15.2,15.3,15.4- Megaloblastic anemia-Int session
12-09-24	Thursday	CP	CP	CP	PA 16.1,16.2,16.4,16.3- Hemolytic anemia -Sickle cell anemia, Thalassemia-SGD	Emerging & re emerging infections		PH 1.39 Drugs used for Contraception (SGD1/Theory)	IDA, Megaloblastic anemia- Practical
13-09-24	Friday	CP	CP	CP	PH 1.52 Toxicology Charts (SGD1/ Practical)	PH 1.52 Toxicology Charts (SGD1/ Practical)		PA 18.2- AML, ALL-L	OSPE
14-09-24	Saturday		holiday
15-09-24	Sunday		holiday
16-09-24	Monday		holiday
17-09-24	Tuesday	PTA	PTA	PTA	PTA	PA 18.1,18.2 CML,CLL-L	PTA	PTA	PTA
18-09-24	Wednesday	CP	CP	CP	CM 6.2,6.3,6.4 DESCRIPTIVE STATISTICS I	CM 6.2,6.3,6.4 DESCRIPTIVE STATISTICS I		PA 17.1,17.2- Hemolytic anemia, aplastic anemia- SGD	PA 21.1-21.4-DIC,ITP,TTP,HUS
19-09-24	Thursday	CP	CP	CP	PA 31.2 CA BREAST	Healthcare Associated infection VAP,CAUTI	LUNCH	PH 5.2 DRUG THERAPY, STORAGE	KALEIDOSCOPE-CME
20-09-24	Friday	CP	CP	CP	PH 5.1 Empathy, Ethics	PH 5.1 Empathy, Ethics		KALEIDOSCOPE-CME	OSPE
21-09-24	Saturday	PANDEMIC MODULE 2.5	IM13.3 INFECTION AND CANCER RELATIONSHIP	FM3.24 Impotence and Sterility 3	KALEIDOSCOPE-CME	KALEIDOSCOPE-CME	Lunch	PH 5.2 DRUG THERAPY, STORAGE	pandemic - cm
22-09-24	Sunday		holiday
23-09-24	Monday	CP	CP	CP	OG17.1 PHYSIOLOGY OF LACTATION	Healthcare Associated infection CRBSI,SSI		PH 2.1 Dosage forms DOAP 1/ Practical	PH 2.1 Dosage forms DOAP 1/ Practical
24-09-24	Tuesday	CP	CP	CP	PH 5.3 ADHERENCE	PA 16.4- Bone marrow aspiration/biopsy-SGD	Lunch	Confidentiality pertaining to patient's identity in lab result	IPC - Standard precautions
25-09-24	Wednesday	CP	CP	CP	CM 6.2,6.3,6.4 DESCRIPTIVE STATISTICS II	FM3.25 Impotence and Sterility 4		HB ESTIMATION, BLOOD GROUPING-THEORY-L	PA 19.6,21.2,21.5-VIT K ,SPLENOMEGALY, HEMOPHILIA-SDL
26-09-24	Thursday	CP	CP	CP	PA 20.1 PLASMA CELL DISORDERS-SGD	IPC - Transmission based precautions		PH 5.3 ADHERENCE	HB ESTIMATION, BLOOD GROUPING-PRACTICAL-SGD
27-09-24	Friday	CP	CP	CP	PH 5.4 COST AND COMPLAINCE	PH 5.5 DEPENDANCE		PA 19.4,19.5-HODGKIN, NONHODGKIN LYMPHOMA-SGD	SPOTTERS
28-09-24	Saturday	yoga	OG 22.1 Leucorrhoea diagnosis and management	FM3.26 Impotence and Sterility 5	INTERNAL ASSESSMENT	INTERNAL ASSESSMENT	LUNCh	pandemic- micro	sports
29-09-24	Sunday		holiday
30-09-24	Monday	CP	CP	CP	IM13.1 EPIDEMIOLOGY AND INHERITED AND MODIFIABLE RISK OF COMMON CANCER	Transfusion Transmissable infections		PH 3.7Essential medicines (SGD/PRACTICAL)	PH 3.7Essential medicines (SGD/PRACTICAL)
01-10-24	Tuesday	CP	CP	CP	PH 1.54 Vaccines and antisera(SDL)	PA 22.4 ENUMERATE BLOOD COMPONENTS -SDL	Lunch	Vaccine preventable diseases	Laboratory-acquired Infection
02-10-24	Wednesday		holiday
03-10-24	Thursday	CP	CP	CP	PA 22.4 BLOOD COMPONENTS & ITS CLINICAL USE -SGD	Hospital Infection Control Committee	LUNCH	PH 1.57 Drugs used in skin disorders (SDL)	PATH PRACTICALS - HEMOGLOBIN ESTIMATION
04-10-24	Friday	CP	CP	CP	PH 1.55 National health programmes (SGD1/Theory)	PH 1.55 National health programmes (SGD1/Theory)		PA 22.4 BLOOD COMPONENTS & ITS CLINICAL USE -SGD	SPOTTERS
05-10-24	Saturday	yoga	SU 12.2 Describe and discuss the methods of estimation and replacement of the fluid and electrolyte requirements in the surgical patient	FM3.27 Abortion 1	PA 22.6. TRANSFUSION REACTION (SGD)	Pharmacology IA-8 CNS		PH 2.6 AETCOM- Bioethics	PH 2.6 AETCOM- Bioethics
06-10-24	Sunday		holiday
07-10-24	Monday	CP	CP	CP	IM14.1 DEFINE AND MEASURE OBESITY	CSSD		PH 2.3 IV Drip setting DOAP1/Practical	PH 2.3 IV Drip setting DOAP1/Practical
08-10-24	Tuesday	CP	CP	CP	1.64 Drug Development & GCP ( L1)	PA 22.5 INFECTIONS TRANSMITTED BY BLOOD TRANSFUSION (SGD)	Lunch	Antimicrobial Stewardship-Integrated class	Antimicrobial Stewardship-Integrated class
09-10-24	Wednesday	CP	CP	CP	CM 6.2,6.3,6.4 INFERENTIAL STATISTICS I	Abortion 2 FM3.28	LUNCH	PA 22.6. STEPS IN INVESTIGATION OF TRANSFUSION REACTION (SGD)	PA 22.7 ENUMERATE INDICATIONS FOR AUTOLOGOUS TRANSFUSION (SGD)
10-10-24	Thursday	CP	CP	CP	PA 22.7 PRINCIPLES & PROCEDURE - AUTOLOGOUS TRANSFUSION (SGD)	ENVIRONMENTAL SURVEILLANCE-Bacteriology of Air,Water and Milk		1.63 Drug Regulations( L1)	PA 22.7 PRINCIPLES & PROCEDURE - AUTOLOGOUS TRANSFUSION (SGD)
11-10-24	Friday		holiday
12-10-24	Saturday		holiday
13-10-24	Sunday		holiday
14-10-24	Monday	CP	CP	CP	OG 27.1 Sexually transmitted diseases	Seminar		PH 3.7Essential medicines (SGD/PRACTICAL)	PH 3.7Essential medicines (SGD/PRACTICAL)
15-10-24	Tuesday	CP	CP	CP	PH 5.6 OTC- SGD 1	PA 20.1 - PLASMA CELL MYELOMA - DOAP	Lunch	Seminar	Seminar
16-10-24	Wednesday	CP	CP	CP	CM 6.2,6.3,6.4 INFERENTIAL STATISTICS II	CM 6.2,6.3,6.4 INFERENTIAL STATISTICS II		PA 22.1 CLASSIFY & DESCRIBE BLOOD GROUP SYSTEMS -SDL	PA 16.7 CROSS MATCHING TECHNIQUE -L
17-10-24	Thursday	CP	CP	CP	PATH PRACTICALS - HEMOGLOBIN ESTIMATION	Practicals IA	LUNCH	PH 5.6 OTC- SGD 1	PATH PRACTICALS - BLOOD GROUPING & TYPING (SGD)
18-10-24	Friday	CP	CP	CP	PH 5.7 Communication skills – Legal and ethical aspects (SGD1/ Practical)	PH 5.7 Communication skills – Legal and ethical aspects (SGD1/ Practical)		PATH PRACTICALS - HEMOGLOBIN ESTIMATION	Practicals IA
19-10-24	Saturday	AETCOM - sur	blood disorders mgt	FM3.29 Infanticide	PATH PRACTICALS - PERIPHERAL SMEAR - INTERPRETATION	Pathology IA 9 SP	Lunch	PH 3.6 Interaction with Pharma Representative	pandemic-cm
20-10-24	Sunday		holiday
21-10-24	Monday	CP	CP	CP	SU 12.3 Discuss the nutritional requirements of surgical patients, the methods of providing nutritional support and their complications	Microbiology		PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)
22-10-24	Tuesday	CP	CP	CP	PH 4.1 ROUTES OF ADMINISTRATION (DOAP 1/ Practical)	PATH PRACTICALS - PERIPHERAL SMEAR - INTERPRETATION	Lunch	Microbiology	Microbiology
23-10-24	Wednesday	CP	CP	CP	CM 3.1Plastic pollution(Seminar)	FM3.30 FM3.31 FM3.33 Medicolegal aspect of injury & Medical Ethics and Law		PATH PRACTICALS - PERIPHERAL SMEAR - INTERPRETATION	PATH PRACTICALS - HPE REQUEST WRITING
24-10-24	Thursday	CP	CP	CP	PATH PRACTICALS - FNAC REQUEST WRITING	Microbiology		PH 3.8 Drug counselling	PATH PRACTICALS - PERIPHERAL SMEAR DEMONSTRATION
25-10-24	Friday	CP	CP	CP	PH 4.2 CAL (SGD1/ Practical)	PH 4.2 CAL (SGD1/ Practical)		PA 23.3 - INTERPRET LIVER FUNCTION TESTS	Microbiology
26-10-24	Saturday	yoga	OG 23.1 PHYSIOLOGY OF PUBERTY	FM3.32 Legal Procedure	Microbiology	Microbiology	LUNCh	pandemic-micro	sports
27-10-24	Sunday		holiday
28-10-24	Monday	CP	CP	CP	SU 11.6 Describe Principles of safe General Surgery	Microbiology		PH 3.2 PA SGD1/ Practical	PH 3.2 PA SGD1/ Practical
29-10-24	Tuesday	CP	CP	CP	PH 3.8 Drug counselling	PA 23.3 - INTERPRET LIVER FUNCTION TESTS	Lunch	Microbiology	Microbiology
30-10-24	Wednesday	CP	CP	CP	CM 8.1 Disinfection(L)	Disinfection(L)		PATH PRACTICALS - urine examinationDEMONSTRATION	Pathology
31-10-24	Thursday		holiday
01-11-24	Friday	CP	CP	CP	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment
02-11-24	Saturday	yoga	SU 11. 4 Enumerate the indications and principles of day care General Surgery	AUTOPSY	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment
03-11-24	Sunday		holiday
04-11-24	Monday	CP	CP	CP	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment
05-11-24	Tuesday	CP	CP	CP	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment
06-11-24	Wednesday	CP	CP		theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment
07-11-24	Thursday	CP	CP	CP	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment	theory summative assessment
08-11-24	Friday	CP	CP	CP	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment
09-11-24	Saturday		holiday
10-11-24	Sunday		holiday
11-11-24	Monday	CP	CP	CP	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment
12-11-24	Tuesday	CP	IM15.1 DESCRIBE AND DISCUSS THE ETIOLOGY OF UGI AND LGI BLEED	CP	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment
13-11-24	Wednesday	CP	CP	CP	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment	practical summative assessment
14-11-24	Thursday	CP	CP	CP
15-11-24	Friday	CP	CP	CP	OG 24.1 Abnormal uterine bleeding -definition and classification	PH 3.8 Drug counselling		PATH PRACTICALS - urine examinationDEMONSTRATION	pandemic - cm
16-11-24	Saturday	PANDEMIC MODULE 2.5	IBS,IBD	AUTOPSY	PATH PRACTICALS - SKILL CERTIFICATION		Lunch	PH AETCOM	PH AETCOM
17-11-24	Sunday		holiday
18-11-24	Monday	CP	OG 18.1 assessment of new born		SU 9.2 Biological basis for early detection of cancer and multidisciplinary approach in management of cancer	Microbiology		PH 3.3 DPL- SGD1/ Practical	PH 3.3 DPL- SGD1/ Practical
19-11-24	Tuesday	CP	SU 5.2 Differentiate the various types of wounds, plan and observe management of wounds.	CP	PH 2.2ORS (SGD1/ Practical)	pathology	Lunch	Microbiology	Microbiology
20-11-24	Wednesday	CP	CP	CP	CM 3.1 Radiation hazards(Seminar)	FM3.30 FM3.31 FM3.33 Medicolegal aspect of injury & Medical Ethics and Law		Pathology	Pathology
21-11-24	Thursday	CP	SUMMATIVE ASSESSMENT 1	CP	pathology	Microbiology		PH 2.2ORS (SGD1/ Practical)	pathology
22-11-24	Friday	CP	CP	CP	PH 2.1 Dosage forms DOAP 1/ Practical	PH 2.1 Dosage forms DOAP 1/ Practical		pathology	Microbiology
23-11-24	Saturday	yoga	OG 32.1 Physiology of menopause	AUTOPSY	Microbiology	Microbiology	LUNCh	pandemic- micro	sports
24-11-24	Sunday		holiday
25-11-24	Monday	CP	CP	CP	SUMMATIVE ASSESSMENT 2	Microbiology		PH 2.1 Dosage forms DOAP 1/ Practical	PH 2.1 Dosage forms DOAP 1/ Practical
26-11-24	Tuesday	CP	CP	CP	PH 2.1 Dosage forms DOAP 1/ Practical	pathology	Lunch	Microbiology	Microbiology
27-11-24	Wednesday	CP	CP	CP	INTERNAL ASSESSMENT-IV	INTERNAL ASSESSMENT-IV		Pathology	Pathology
28-11-24	Thursday	CP	CP	CP	pathology	Microbiology	LUNCH	PH 2.1 Dosage forms DOAP 1/ Practical	pathology
29-11-24	Friday	CP	CP	CP	PH 3.5 P-drug (SGD1/ Practical))	PH 3.5 P-drug (SGD1/ Practical))		pathology	Microbiology
30-11-24	Saturday	yoga	CP	AUTOPSY	Microbiology	PH 3.4 ADR REPORTING		MI AETCOM	MI AETCOM

Phase II Annual Planner 2024-25

Quick Links

Our Departments

Contact Us

General Enquiries

General Enquiries

Community Hotline – Feedback and Complaints